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The concentrations of the androgen conjugate DHA sulphate in human
breast fluids and breast tissue have been studied. It has been
shown that DHA sulphate is present within breast secretions, breast
cyst fluids and breast tissues in much higher concentrations than
those found in plasma.
The levels of DHA sulphate in breast cyst fluid have been shown to
correlate directly with the K+ content and inversely with the Man-
content of the fluid. On the basis of the concentrations of K+, Na+
and DHA sulphate, it was possible to define two populations of
breast cyst fluids and evidence has been presented to show that
these are derived from different types of epithelium. One group
of cysts are lined by apocrine epithelium and contain high
concentrations of K+ and DHA sulphate and low concentrations of Na+.
The other group are lined by flattened epithelium and have the
reverse composition (low [K+], low [DHA sulphate], high [Na+]).
Other components of cyst fluid also correlate directly with the
nature of the epithelial lining.
The natural history of cystic disease has been shown to be closely
related to cyst type and therefore to the composition of cyst fluid.
Patients with apocrine cysts appear more likely to have multiple
simultaneous cysts and more commonly develop sequential cysts.
These patients are also more likely to have within their breasts
lesions which are known to be risk factors for subsequent breast
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cancer. Furthermore, a study of a group of patients with breast
cancer showed a significantly greater number had a history of
apocrine rather than flattened cysts. These findings suggest that
patients with apocrine cysts may be at a relatively increased risk
of subsequent breast cancer.
A study of the precursors of palpable breast cysts, microcysts,
identified only a single population. Microcysts contain massive
amounts of DHA sulphate, high levels of K+ and appear to be lined by
epithelium with marked apocrine features.
Using an immunoperoxidase technique DHA sulphate was visualised in
human breast secretions, apocrine epithelium and a proportion of
human breast cancers. The amount of DHA sulphate present in
carcinomas was greatest in these tumours which had a marked degree
of apocrine differentiation.
These observations suggest that DHA sulphate is a marker of apocrine
activity. Its presence within the breast is in keeping with the
breast being a modified apocrine gland. Measurement of DHA sulphate
within the breast may therefore give useful information on the
degree of apocrine activity of the breast. Measurement of this
hormone in breast cyst fluid appears to be particularly useful, as
it gives information both on the likely natural history of the
disease and appears to identify those patients at increased risk of
epithelial proliferation.
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The mammary gland is a complex endocrine target organ, its growth
and secretory differentiation depending on an interplay of
pituitary, ovarian, thyroid, adrenal and pancreatic hormones (Robyn
1983).
Growth is largely under the influence of oestrogens and
progesterone. Oestrogens alone can promote the development of
breast ducts and in synergism with progesterone, promote growth of
lobules (Van Bogaert 1976, Robyn 1983). Differentiation of the
breast epithelium is also influenced by oestrogens whilst
progesterone has an effect on interlobular ducts (Bolander et al
1980). During pregnancy a combination of oestrogens, progesterone
and prolactin stimulate growth of the terminal duct-lobular units.
The presence of high concentrations of sex steroids and human
placental lactogen inhibit lactogenesis in pregnancy but, after
delivery, the fall in sex hormones results in lactogenesis due to
the unopposed action of prolactin (Robyn 1983). The whole of this
process of growth and differentiation is, however, only achieved in
the presence of insulin, Cortisol and thyroxine (Cowie et al 1980).
Hormones are thus the major factors in the development and growth of
the normal breast. It thus follows that abnormalities of growth may
reflect abnormalities in hormone levels. There is strong
epidemiological evidence to suggest that hormones have an
aetiological role in the development of benign and malignant breast
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disease (A Miller et al 1980). Both diseases are more prominent in
females than males. The incidence of cystic disease, the commonest
benign condition of the breast, varies during reproductive life
occurring in late premenopausal and perimenopausal women with
symptoms disappearing after the menopause (Haagensen 1971,
Marchesoni et al 1983). With regard to breast cancer,
oophorectomy before the age of 35 markedly reduces risk, whereas
risk is increased by a late natural menopause (MacMahon et al 1973).
A link also exists between breast cancer and parity, age at first
pregnancy and anovulatory cycles (Shapiro et al 1968, MacMahon et al
et a I
1973, Sherman et al 1974, Mauvais-Jarvis^l975, Korenman 1980a,
Korenman 1980b, Kalache et al 1982).
Despite this evidence, studies of hormones in both plasma and urine
of women with benign and malignant breast disease have yielded
conflicting results. However, there are two important findings
which are worthy of mention.
The first relates androgens and breast cancer - Bulbrook and Hayward
(1967) collected urine from 4850 normal women on the island of
Guernsey and later analysed the urine of women who developed cancer
along with carefully matched controls. They showed that those women
who developed breast cancer had significantly lower concentrations
of aetiocholanolone in their urine than controls. This finding is
particularly important as the abnormality in the urine was present
before the disease was detected clinically. Aetiocholanolone in the
urine is largely derived from plasma DHA sulphate and other related
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C19 steroids. Studies of DHA and DHA sulphate in plasma have also
indicated that patients at risk of breast cancer may have lower
levels than controls (Wang et al 1975, Wang et al 1979), although
this remains disputed (Chetty et al 1983). The role of these
androgens in breast disease may be indirect. In postmenopausal
women adrenal androgens provide the major precursors of oestrogens
with conversion occurring peripherally (MacDonald et al 1967). It
is of note that adipose tissue and breast tumours can also
perform this conversion (Abul-Hajj et al 1975, Adams et al 1975,
Miller et al 1976, Varella et al 1978).
The second series of observations relate to oestrogens and
progesterone. There is evidence that anovulatory cycles, which
occur at the extremes of reproductive life, may be related to benign
and malignant breast disease (Mauvais-Jarvis 1979, Korenman 1980b,
et al
Ber ta et al 1983, KuttennjM983). In these situations, oestrogenic
stimulation of target tissues occurs without the opposing action of
progesterone. Support for this also comes from the finding that
there is an inverse correlation between plasma progesterone and
breast cancer risk (Bulbrook et al 1978). However, it should be
noted that not all women with breast cancer have anovulatory
cycles and not all women with anovulatory cycles develop benign or
malignant breast disease (Korenman 1980b).
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Although both these studies are convincing as individual
investigations, these have not been confirmed by others and thus it
is yet to be proven that abnormalities in plasma hormones are
commonly associated with benign and malignant breast disease.
One possible explanation for the failure to identify consistent
differences is that hormone levels in plasma and urine may not
accurately reflect concentrations within the breast. There is
difficulty, however, in obtaining information on tissue levels of
hormones in the normal and diseased breast. Certain fluids can be
obtained from the breast and include, milk during lactation, breast
secretions collected from non-pregnant women by nipple aspiration
(Sartorius 1973) and cyst fluid obtained by needle aspiration from
patients with cystic disease.
Milk has a constant composition, is produced only in pregnancy or in
association with hyperprolactinaemia and does not reflect the
hormonal environment of the resting breast (Kulski et al 1977, Yap
et al 1980).
In contrast, breast secretions and cyst fluid are more widely
available and, as they are derived from the resting breast, may
provide more representative information on breast hormone levels, at
times when breast disease is being induced. Results from analysis
of these two fluids have shown concentrations of oestrogens and
androgens which are greatly in excess of those in plasma (Miller et
al 1977, Raju et al 1977, Wynder et al 1977, Bradlow et al 1979,
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Miller et al 1980, Bradlow et al 1981a, Miller et al 1981, Miller et
al 1982, Bradlow et al 1983a, Bocuzzi et al 1983, Miller et al
1983). The androgen conjugate DHA sulphate, has been found in breast
secretions at concentrations from 7 to 400 times greater than those
in plasma and in cyst fluids at up to 100 times greater
concentrations (Miller et al 1980, Miller et al 1981, Miller et al
1982, Miller et al 1983). It thus appears that hormone levels
within plasma may not reflect those in the breast. At present,
however, neither the origin nor the factors that affect the
concentration of these hormones and their conjugates in breast
derived fluids have been defined.
The aims of the present study were thus:
(1) to define further the composition of breast secretions and
breast cyst fluids
(2) to investigate the origin of these fluids
(3) to determine factors which affect their composition
(4) to correlate composition of cyst fluids to the course of the
disease and the associated risk of breast cancer
(5) to investigate the concentration of DHA sulphate in breast
tissue and breast carcinomas and determine what factors
influence these levels.
15
GENERAL MATERIALS AND METHODS
Materials
All chemicals, with the exception of those mentioned below, were
Analar grade and obtained from BDH Chemicals, Poole, Dorset.









Toluene scintillation grade Fisons, Loughborough,
England
Sephadex LH 20 Pharmacia Fine Chemicals,
Uppsala, Sweden





















DHA sulphate assay buffer
2g gelatin, 2g sodium azide, I8g sodium chloride, 21.8g disodium
hydrogen orthophosphate dihydrate and 12.4g sodium dihydrogen
orthophosphate were dissolved in 2 litres of distilled water. Final
pH 7.0.
Phosphate buffered saline (PBS)
0.6 g sodium dihydrogen orthophosphate, 5.7 g disodium hydrogen
orthophosphate and 17.Og NaCl were dissolved in 1 litre of
distilled water. Final pH 7.6.
Tris HC1 buffer
38.5 ml 0.1 M HC1, 50 ml 0.1H Tris (12.114g/l) and 11.5ml distilled
water pH 7.6.
Wolpoles buffer




0.1 M sodium cacodylate was dissolved in distilled water made to pH
7.0 by addition of IN HC1.
Other solutions
Hexazotised pararosaniline
Solution A : pararosaniline 1g
2N HC1 25ml
Heat gently, cool and filter
Solution B : sodium citrate 4g
distilled water 100ml
before use equal parts of solutions A and B were added.
Dextran Coated Charcoal
0.625g/S activated charcoal suspended in DHA sulphate assay buffer
containing 0.0625g? Dextran T 70.
Scintillation fluid
200ml Scintol 7 and 4800ml Toluene.
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SchiffIs reagent
1g of basic fuchsin was dissolved in 200ml of boiling water and
allowed to cool to 50°C before adding 2g of potassium
metabisulphite. The mixture was allowed to cool before adding 2ml
of concentrated hydrochloric acid and 2g of activated charcoal. This
was left overnight in the dark at room temperature. The mixture was
then filtered and ready for use.
Antibodies
The anti DHA antibody was kindly donated by Mr B Morris of the
Department of Biochemistry, University of Surrey. This antibody was
*
raised in sheep and its specificity has been previously defined
(Table I). Peroxidase conjugated rabbit immunoglobulins to sheep
immunoglobulins was obtained from DAKO immunoglobulins, Denmark.


















All values are the mean of three determinations.
Cross reaction calculated from ratio of molar mass of DHA sulphate
to cross-reacting steroid, required to displace 50$ of the
radioligand, multiplied by 100.
Table I Cross-reactivity of various steroids with the anti DHA
antibody (from Miller et al 1980)
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Method of obtaining breast secretions bv nipple aspiration
Breast secretions were obtained by one of two research nurses in the
Department of Clinical Surgery by a standard technique. This
technique which utilises the Sartorius suction cup as shown in
Figure 1 is demonstrated in Figures 2 to 5. The nipple was first
carefully cleaned with alcohol. Following this, the breasts were
massaged, starting at the periphery of the breast and moving
centrally towards the nipple. The suction cup was then placed over
the nipple and negative pressure applied using a 20 ml syringe.
Following this, if the woman produced secretions, these could be
seen on the surface of the nipple and collected in a capillary tube
of known diameter. All samples were then stored at -20°C prior to
analysis.
Purification of 3_h DHA
DHA was purified by chromatography on Sephadex LH20 prior to use.
Between 20 and 40 ji Ci of 3h steroid was dissolved in
benzenerethanol (9:1 v/v) and placed on a Sephadex LH column (15 x 1
cm). Elution was carried out with benzene rethanol (9:1 v/v). One
ml fractions were collected and the radioactivity monitored in each
by counting 10 ^il aliquots. The fractions with peak radioactivity
were bulked together, dried down at 60°C under air and dissolved in
0.2 ml of ethanol. These stock solutions were then stored at 4°C
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Figure 1 Sartorius nipple aspiration cup
Method of obtaining breast secretions using the
Sartorius nipple aspiration cup
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and diluted when required with assay buffer to form an appropriate
working solution on the day of the assay.
Radioimmunoassay for DHA sulphate
This was performed using the method of Buster and Abrahams (1973).
Samples of plasma, breast cyst fluid and breast secretions were
diluted from between 50 and 1,000,000 times (v/v) with assay buffer
and 0.5 ml assayed in duplicate as follows:
The samples were cooled to 4°C and incubated at that temperature
overnight with 0.1 ml anti DHA antibody (diluted 1 in 27,500 v/v
with assay buffer) and 0.1 ml [1,2,6,7 3fj] DHA (containing
approximately 10,000 cpm in assay buffer). Bound steroid was
then separated from free by the addition of 0.2 ml of dextran coated
charcoal at 0°C. After 20 minutes the samples were centrifuged at
2500 rpm for 10 minutes at i+°C. The supernatant containing the
bound fraction was decanted into glass scintillation vials
containing 10 ml of scintill ant, mixed and incubated for 2 hours
at 37°C. The vials were then cooled to i4°C and counted x 2 for 10
minutes using a Packard Tri Carb Liquid Scintillation Spectrometer.
With each assay, known amounts of unlabelled DHA sulphate (0.025 - 5
ng/0.5 ml assay buffer) were taken through the assay so that a
standard curve (cpm v log ng/0.5 ml DHA sulphate) could be plotted.
The values for unknown samples were then calculated by determining
the DHA sulphate in each diluted sample from the standard curve and
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multiplying by the diluting factor. Standard plasmas, cyst fluids
and breast secretions were also taken through each assay so that
interassay variation could be corrected for. Having determined the
value in ng/ml, these values were then converted to jx mol/1.
Because the antibody used in the assay cannot distinguish between
DHA sulphate (Table I) and DHA, the result obtained represents the
sum of both. However in all samples studied the amount of DHA
sulphate is many hundred times greater than that of DHA and
therefore the value obtained essentially reflects DHA sulphate
concentrations (Miller et al 1980, Mason 1981).
Estimation of Na+ and K+ concentrations in breast fluid
This was performed by flame photometry on a 1 in 200 or a 1 in 400
dilution of breast cyst fluid or breast secretion in distilled water
using an EEL model 150 flame photometer. Standard solutions
containing known concentrations of Na+ and K+ were used on each
occasion, to calibrate the machine and to check its accuracy during
a series of measurements.
DHA sulphate localisation bv Immunoperoxidase
Attempts were made to localise DHA sulphate in (i) formalin fixed
tissue embedded in paraffin; (ii) frozen sections of formalin fixed
material; and (iii) frozen sections of fresh tissue. Only on frozen
sections of fresh tissue was positive staining obtained. This is
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probaby due to DHA sulphate being extractable into both water and
alcohol.
Frozen sections cut at between 3 and 5 Jim were washed in PBS for 1
minute. The tissues were then incubated for 30 minutes in 10$
normal rabbit serum (NRS). The slides were drained of excess serum
and wiped. The sections were then incubated for 30 minutes with a 1
in 50 dilution of sheep antiserum to DHA diluted in 10$ NRS
and 5$ normal human serum from a patient taking aminoglutethimide
and whose plasma was known to contain almost undetectable levels of
DHA sulphate. As a control, serial sections were incubated with a 1
in 10 dilution of normal sheep serum diluted in 10$ NRS. After
rinsing with the changes of PBS for 10 minutes, peroxidase
conjugated rabbit anti sheep antibody diluted 1 in 50 in 10$ NRS and
5$ human serum was added for 30 minutes. The sections were rinsed x
3 for 10 minutes in PBS then a solution of DAB, 5 mg in 10 ml of
Tris HC1 buffer with 75 }il of hydrogen peroxide was applied for 5
minutes. The sections were then washed in water, counterstained
with haematoxylin, dehydrated in graded alcohols and xylene and
mounted with Permount.
A section of axillary skin containing apocrine glands and sections
of human adrenal gland were used as positive controls (Figures 6,7).
Human ovarian stroma was used as a negative control (Figure 8).
Primary antisera absorbed with DHA sulphate was also substituted as
a second negatively staining control as a test for the specificity
of the antibody staining reaction.
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Figure 6 Human apocrine glands from axillary skin stained with, the
immunoperoxidase technique to show the presence of DHA
sulphate - positive control - (H & E and frozen section x 200)
* .
Figure 7 Human adrenal gland stained for DHA sulphate - positive
control (frozen section x 800)
Figure 8 Human ovarian stroma stained for DHA sulphate - negative
control (frozen section x 200)
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PAS Diastase Stain
Tissues were fixed in "\0% formalin solution, processed, embedded in
paraffin wax and 3 sections cut. These were dewaxed and then
incubated for 1 hour at 37°C in 1 g of diastase in 100 ml of
distilled water. The slides were then washed in water for 5-10
minutes before being treated with periodic acid (1 g in 200 ml
distilled water) for 5 minutes. The tissues were then washed in
water and covered with Schiff's reagent for 15 minutes. The slides
were then again washed in tap water for 5 to 10 minutes,
counterstained with haematoxylin, dehydrated in graded alcohols and
xylene and mounted with Permount.
Acid phosphatase
Frozen sections were incubated for 30 minutes at 30°C in a solution
of alpha naphthol As B1 phosphoric acid 20 mg, acetone 1 ml,
Wolpoles buffer 22.5 ml and hexazotised pararosaniline 0.9 ml.
Tissues were then washed in water, counterstained with haematoxylin,
dehydrated through graded alcohols and mounted from xylene in
permount synthetic resin.
Electron Microscopy
Tissues were fixed in 355 glutaraldehyde in 0.1 m cacodylate buffer
overnight. They were then rinsed x 2 in buffer for 30 minutes
before being further fixed in 156 osmium tetraoxide. Tissues were
then dehydrated through graded alcohols and placed in epoxypropane
before being impregnated overnight in araldite. Sections were cut
using a glass knife at 900 nm thickness and stained with uranyl
acetate before being viewed on a Jeol 1005 electron microscope.
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Evidence that Eadloiiirojnoassay is measuring DHA Sulphate
(Miller et al 1980, Miller et al 1982, Miller 1985 personal communication)
(1) If fluids are extracted with ether, then <1% of the material
cross-reacting with the antibody is in the aqueous phase. This indicates
that the substance being measured is not a free steroid, ie. it cannot be
DHA, Cortisol, testosterone etc.
(2) Acid solvolysis of fluids followed by ether or ethyl acetate
extraction results in the cross-reacting material passing into the organic
phase. This indicates the substance being measured is a conjugate.
(3) Saturation of fluids with sodium chloride followed by extraction into
an organic solvent drives the cross-reacting material into the organic
phase. The substance is therefore not a protein.
(4) On thin layer chromatography the cross-reacting material migrates with
DHA Sulphate and following solvolysis migrates with DHA.
(5) The mass spectrum (MS) of the major component of solvolysed extracts
after gas liquid chromatography (GLC) closely resembles that of authentic
DHA. Quantitative estimates by GLCMS of DHA in solvolysed extracts of
plasma and breast secretions are almost identical to those obtained by
radioimmunoassay of DHA after a correction has been made for procedural
losses. In cyst fluids the values obtained by radioimmunoassay and GLCMS
also show reasonable correlation. In some cyst fluids the value of DHA
Sulphate was lower, but of the same dimension by GLCMS. In these fluids
significant amounts of androsterones sulphate and epiandrosterone sulphate
were detected by GLCMS. It is of note that the antibody cross-reacts with
these substances (Table 1). Values obtained for cyst fluids therefore
principally reflect DHA Sulphate but also include closely related 17
oxo-steroid conjugates, although for simplicity in the text they will be
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Introduction
Studies of normal mature non-lactating breasts reveal secretions
within lobules, ductules and ducts (Bonser et al 1961). This
secretion is seen on staining with haematoxylin and eosin as pale
pink material (Figure 1). In periodic acid Schiff stained
sections, secretions stain a brilliant violet with paler pink areas
(Figure 2). During pregnancy, this staining pattern is lost,
indicating that the secretion produced by lactating lobules is
different to that produced in the breast of non-lactating breast
(Bonser et al 1969). Due to a combination of reabsorption of the
secretion and the keratin plugs present in the orifices of the main
ducts opening onto the nipple in non-pregnant women, breast
secretions in the non-lactating breast rarely escape.
Several investigators have been able to obtain secretions from
the nipples of non-lactating women using various types of breast
pump (Adair et al 1931, Jackson et al 1951, Papanicolaou et al 1958,
Sartorius 1973). These fluids were first used to obtain cells from
the breast for cytological analysis in the hope of devising a
screening test for breast cancer (Sartorius 1973). However, not all
women produce breast secretions. Petrakis et al (1975) investigated
the factors which influenced the availability of these secretions.
They were able to obtain breast secretions from approximately half
of all women. Fluid was obtained from a greater proportion of
Caucasian than Chinese women and more commonly from premenopausal
women and those under 50 years of age. The phase of the menstrual
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Figure 1 Normal human breast lobule containing lobular secretion
(H & E x 200)
Figure 2 Normal human breast lobule containing lobular secretion.
Note the two different colours of secretion indicating
two different forms of mucopolysaccharide in the
secretion (AB. PAS x 100)
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cycle, parity and whether the patient was taking the pill did not
have any apparent effect. It was also noted that women with wet
type cerumen had a higher incidence of production of breast
secretion, indicating that genetic factors may be important in
influencing the secretory activity of the non-lactating breast
(Petrakis et al 1975).
More recently, the composition of these fluids has been studied.
Breast secretions from non-lactating women have been shown to
contain high levels of cholesterol, triglycerides, free fatty acids
(Petrakis et al 1977c, Petrakis et al 1981), secretory IgA (Petrakis
et al 1977b, Yap et al 1981), hormones (Miller et al 1977, Wynder et
al 1977, Miller et al 1977, Miller et al 1980, Wynder et al 1981,
Miller et al 1983) and, in smokers, nicotine (Petrakis et al 1978),
It has been noted that the concentrations of these substances
frequently exceed those found in plasma. For example, the androgen
conjugate DHA sulphate which, in plasma, is almost exclusively
derived from the adrenal cortex, may be present in breast secretions
at levels up to 400 times greater than its plasma concentration
(Miller et al 1980, Miller et al 1981, Miller et al 1 983). It is
not known what influences the composition of these secretions,
although it has been suggested that hormone composition of these
fluids may be related to the pathogenesis of breast disease
(Petrakis et al 1975, Wynder et al 1977). It is also of interest
that mutagens have been detected in breast secretions with a
frequency similar to the incidence of breast cancer in the
population (Petrakis et al 1980).
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Despite the studies on composition of breast secretions, little is
known about the mechanisms involved in the production of these
fluids and the factors affecting their composition. It is assumed
that they are secreted by the lobular units of the breast and
possibly are modified as they pass down the duct system. This is,
however, far from proven. The finding of large amounts of DHA
sulphate in breast secretions offers a possible marker to study
these processes.
Some studies have been performed on DHA sulphate in breast
secretions and these have shown that values in any individual are
consistent in both breasts and remain constant throughout the
menstrual cycle. As yet, no differences in levels of DHA sulphate
in breast secretions from normal women, those with benign disease




(i) Measurement of DHA sulphate, Na+ and K+ in breast secretions
obtained by nipple aspiration
(ii) Immunoperoxidase localisation of DHA sulphate within the
normal breast
(iii) Concentration of DHA sulphate in secretions obtained from
within the breast parenchyma





(i) Measurement of DHA sulphate. Na+ and K+ in breast secretions
obtained bv nipple aspiration
The aim of this study was to confirm that high levels of DHA
sulphate were present in human breast secretions obtained by nipple
aspiration and also to measure Na+ and K+ in these fluids.
Patients. Materials and Methods
Sixty breast secretions from 48 patients had DHA sulphate estimated
by radioimmunoassay. Na+ and K+ were measured by flame photometry.
Results
The values of DHA sulphate in the 60 breast secretions are shown in
Figure 1. All DHA sulphate concentrations in these secretions were
above the upper limit of the reference range for plasma. The Na+
and K+ concentrations in these 60 secretions are shown in Figure 2.
The range for Na+ was 96-244 mmol/1 and for K+ was 5-30 mmol/1.
Breast secretions therefore contain higher concentrations of K+ than
does plasma; however Na+ concentrations were always greatly in
excess of those of K+. This is more clearly demonstrated when the
ratio of Na+ to K+ in breast secretions is plotted (Figure 3).
There was no significant correlation between the values of DHA

















Figure 1 Concentration of DHA sulphate in human breast secretions









































Figure 3 Na+/K+ ratio in breast secretions obtained by nipple
aspiration
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(ii) Concentration of DHA sulphate in secretions from within the
breast parenchyma
It is considered that breast secretions obtained from the nipple are
derived from secretion by the lobular units of the breast and are
modified as they pass through the duct system. The aim of the
present study was to determine the concentration of DHA sulphate
from fluid obtained from terminal and interlobular ducts and from
major ducts leading to the nipple.
Materials and Methods
Seven mastectomy specimens from seven patients with breast carcinoma
were carefully sectioned into thin slices and examined under a
dissecting microscope. Secretions were obtained from visible
terminal and interlobular ducts (Figure 4) and collected into
calibrated capillary tubes at sites distant from the breast cancer.
Secretions from larger ducts were visible macroscopically and
collected in a similar manner.
The secretions were diluted in distilled water and stored at -40°C
for later analysis. DHA sulphate was measured in each sample by
radioimmunoassay. Comparison of DHA sulphate concentrations in the
two groups was by the Wilcoxon Rank Sum test.
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Figure 4 The interlobular ducts of the breast as seen under the
dissecting microscope (x 25)
Results
Fourteen samples of secretions from terminal breast ducts were
obtained from the seven specimens. The volumes obtained ranged from
0.5 - 3.5 |il . Nine secretions were obtained from larger ducts,
the volumes ranging from 1 - 13 ^al .
The concentrations of DHA sulphate in these two groups of secretions
are shown in Figure 5. All values for DHA sulphate in the major
duct secretions were higher than those secretions obtained from
terminal ducts. The difference between the groups was also
statistically significant p < 0.01. The concentration of DHA
sulphate within the major ducts is similar to that reported to
breast secretions obtained from the nipple,shown in Figure 1.
The ratio of DHA sulphate in secretions from terminal ducts to that
in the major ducts was not constant, but varied from approximately 3
to 15 times. Thus, the concentrations of DHA sulphate within the
major ducts do not reflect the concentration deep within the breast
and it is not possible to determine this concentration by knowing















Figure 5 Concentration of DHA sulphate in small and large ducts
within the breast
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(iii) Immunoperoxidase localisation of DHA sulphate in the normal
breast
The aim of this study was to localise DHA sulphate within lobules,
ducts and connective tissues within the normal breast.
Materials and Methods
Frozen sections of normal breast were obtained from bilateral
reduction mammoplasties performed in two patients. DHA sulphate was
localised in frozen sections by the method previously described.
Results
The secretions in normal breast lobules contained material cross-
reacting with the antibody (Figure 6), thus suggesting that these
contain concentrations of DHA sulphate greater than in plasma or
surrounding tissues. There was little or no apparent staining
within the cytoplasm of normal breast lobular epithelium. There was
no localisation of DHA sulphate to intralobular or interlobular
stroma. The secretions in breast ducts also contained large amounts
of materials cross-reacting with the antibody and the staining
appeared deeper than in the lobules, possibly indicating a higher
concentration of DHA sulphate within ductal secretions (Figures 7
and 8). Staining was also seen related to ductal epithelium (Figure
9). It was uncertain whether this was present in the cytoplasm of
these cells or between the cells.
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Figure 6 Normal breast lobule stained by the immunoperoxidase
technique to demonstrate DHA sulphate. Note the staining
in the lobular secretions.
Figure 7 Normal breast stained to demonstrate DHA sulphate. Note
the deeper staining within breast ducts.
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Figure 9
Further examples of DHA sulphate within the breast visualised by
the immunoperoxidase technique - note the staining between the
ductal epithelium in Figure 9
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The aim of the present study was to try and determine whether the
DHA sulphate present in breast secretions is concentrated from
plasma or synthesised within the breast. To attempt to answer this
question, breast secretions obtained by nipple aspiration and plasma
from normal women and patients with breast cancer have been
collected on different occasions after taking pharmacological agents
which have been reported to increase or decrease plasma levels of
DHA sulphate.
Women with hyperprolactinaemia may have elevated levels of DHA
sulphate (Bassi et al 1977, Guist et al 1977, Vermeulen et al 1977,
Vermeulen et al 1978). Drug induced hyperprolactinaemia has
similarly been reported to be associated with increased plasma DHA
sulphate concentrations. Metoclopramide in some, but not all
patients, produces hyperprolactinaemia (Schyve et al 1978, Vermeulen
et al 1978). The administration of metoclopramide may therefore be
expected to produce an increase in plasma levels of DHA sulphate.
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The administration of corticosteroids in pharmacological doses
suppresses adrenal output and thus reduces the circulating level of
DHA sulphate. Aminoglutethimide, an agent used in the treatment of
breast cancer, given in combination with Cortisol replacement,
reduces levels of plasma oestrogens and precursors (Santen et al
1980, Mason 1981). Plasma DHA sulphate levels are reduced to less
than 5% of their pre-treatment value.
Patients. Materials and Methods
Two groups of four normal women were studied before, during and
after treatment with either prednisolone 15 mg/day or metoclopramide
30 mg/day according to the following protocol:
Day 0 : Plasma and breast secretions collected.
Day 1 : Either prednisolone or metoclopramide started.
Day 8 : Plasma and breast secretions collected.
Drug stopped.
Day 15 : Plasma and breast secretions collected.
Two patients with breast cancer taking aminoglutethimide 1 g/day and
hydrocortisone 40 mg/day had plasma and secretions collected before
and between 14 and 21 days after treatment.
DHA sulphate concentrations were measured in all samples of plasma
and breast secretions by radioimmunoassay.
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Results
Metoclopramide had no significant effect on the concentration of DHA
sulphate either in plasma or in breast secretions (Figure 10).
Prednisolone markedly reduced plasma DHA sulphate levels and also
lowered the concentration of DHA sulphate in breast secretions,
although this effect was not as great as that in plasma (Figure 10).
It was also evident that the post-prednisolone samples of plasma and
secretions did not attain the same concentration of DHA sulphate as
in the original specimens.
Aminoglutethimide produced more marked falls in the level of DHA
sulphate in both plasma and secretions (Figure 11). As with
















Figure 10 Effect of Metoclopramide(Maxolon) and Prednisolone on
the concentration of DHA sulphate in plasma and breast
secretions (0 - ti me zero,]-drug fori week . 2 - 1 week
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Figure 11 Effect of Aminoglutethimide on the concentration of DHA
sulphate in breast secretions
52
DISCUSSION
The secretions produced by the human breast lobular epithelium have
been shown in the present study to contain concentrations of DHA
sulphate many times greater than those in plasma. This
concentration increases as the secretion passes up to the nipple,
presumably as a result of reabsorption of fluid. The degree of this
increase appears to vary in different breasts and thus measurement
of DHA sulphate in secretions obtained from the nipple will not
directly reflect the concentrations present within the breast
lobules, although it may give a more accurate assessment than
measurement of DHA sulphate in plasma. It is in the lobules that
the majority of breast diseases arise and it may be that the only
concentrations of hormones which are important in relation to the
aetiology of breast disease are those in contact with these cells.
This may explain why studies of hormones in plasma, urine and in
secretions obtained by nipple aspiration have failed to show
consistent differences between groups of normal women and those with
breast disease.
The sources of DHA sulphate in breast and apocrine secretion is
unknown. The present study has shown that reduction of plasma DHA
sulphate levels by the administration of drugs results in a decrease
in DHA sulphate concentrations within breast secretions. The fall
was less marked than in plasma but it may be that a more prolonged
course of treatment would have resulted in a further lowering of
levels in secretions. This is supported by the greater reduction in
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DHA sulphate in the patients taking aminoglutethimide who were
studied between 2 and 3 weeks post-treatment. These findings
suggest that DHA sulphate may simply be concentrated from plasma
sources in a similar manner to the entry of DHA sulphate into breast
cyst fluid (Bradlow et al 1981a, Bradlow et al 1983a). However,
both prednisolone and aminoglutethimide reduce the concentrations of
other steroid hormones and the present observations do not rule out
the conversion of other steroid hormones to DHA sulphate within the
lobular epithelium.
The breast is said to be a modified apocrine sweat gland (Petrakis
et al 197^). Secretion from apocrine sweat glands has also been
noted to contain high concentrations of DHA-sulphate (Labows et al
1979). The concentration of DHA-sulphate within the secretion in
the breast lobules may therefore represent the degree of apocrine
secretory activity of the breast. It is of note that the degree of
apocrine activity in the breast has been related to the risk of
developing breast cancer (Petrakis et al 1977a).
The role of DHA and its sulphate within secretions remains unknown.
It is known that these compounds can be converted to both active
androgens and active oestrogens. This has been demonstrated in
normal, benign and malignant breast tissue (Abul-Hajj 1975, Miller
et al 1979, Miller 1984). It may be that a variation in
concentrations of these substrates may relate to the local levels of
active hormones. Thus the levels of DHA sulphate in breast lobular
secretion may be of importance in the aetiology of breast disease.
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BREAST CYSTS AND CYSTIC DISEASE
Introduction
Cystic disease of the breast is a term used to cover the condition
in which palpable cysts are the dominant feature. These may be
accompanied by several microscopic lesions including (i) microcysts;
(ii) apocrine epithelium; (iii) adenosis; (iv) hyperplasia; and (v)
fibrosis. Some 7% of all women in the Western world develop a
palpable breast cyst (Haagensen et al 1981). The true incidence of
cystic disease, as determined in post-mortem studies, is
approximately 20% for macroscopic cysts and 55% for microcysts
(Frantz et al 1951, Davis et al 1964). It is thus by far the most
common benign disease of the breast. Despite its frequency, little
is known of the origin, mode of formation and content of breast
cysts. This is perhaps even more surprising in view of the
association between cysts and epithelial hyperplasia and the
suggestion that patients with cystic disease may be an increased
risk of subsequent breast cancer.
A more detailed consideration is now presented of the origin, mode
of formation and composition of human breast cysts and the
relationship of cystic disease to hyperplasia and breast cancer.
Origin and mode of formation
Astley Cooper (1829) first distinguished cysts from malignant
transformations. The first comprehensive clinical and pathological
descriptions of cystic disease were made over half a century later
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by Reclus (1883) and Brissaud (1884). Reclus showed that his
"maladie kystique des mammelles" was frequently bilateral, might
involve the whole of the gland and that most cysts were impalpable.
He regarded cysts as independent new formations. In contrast,
Brissaud (1884) thought cysts arose by proliferation of lobular
epithelium to form compact cellular masses, which became cystic
following central necrosis. This theory was later supported by
Schimmelbusch (1890). Konig (1893) considered cysts to be
inflammatory in origin and called the condition chronic cystic
mastitis, a term which remains in common use.
During the early part of the twentieth century, it was believed that
cysts arose as a consequence of senile involution in the breast
(Tietze 1900, Bloodgood 1906, McFarland 1922). An extreme proponent
of the involutional theory was McFarland (1922), who found cysts
only in breasts of women who had lactated and considered them as
variations of the involutional process of lactational lobules.
Other workers could find no evidence of residual lactational lobules
(Semb 1928) and returned to the theory originally proposed by Reclus
(1883) that cysts were new formations arising by hyperplasia.
The role of apocrine epithelium in cystic disease was first
recognised by Creighton (1902). The observation that cysts were
frequently lined by this epithelium led to the view that cysts were
derived from apocrine sweat glands. These glands were thought by
some to be normally present in the breast (Nicholson 1923, Ewing
1940) and by others to be present as a result of a developmental
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anomaly (Krompecher 1913, Von Saar 1907). Studies have now shown
that apocrine epithelium is not present within the breast in early
life and may be found in direct continuity with normal ductal
epithelium, making the theory of a sweat gland origin for cysts
untenable (Cheatle et al 1931, Dawson 1932, Bonser et al 1961). It
is now accepted that apocrine epithelium in the breast arises as a
result of a transformation from normal duct or lobular epithelium
(Bonser et al 1961). This transformation may or may not be a true
metaplasia (Dawson 1932, Lendrum 1945, Haagensen et al 1981). It is
also now appreciated that, although the majority of cysts are lined
by apocrine epithelium, some are lined by flattened epithelium
et al
(Azzopardi 1979, HaagensenjM981). It has been suggested that simple
flattened cysts arise by lobular dilatation, whereas apocrine cysts
arise from lobules in which apocrine change is already present
(Wellings, Jensen and Marcum 1975, Wellings 1980). This is disputed
by others who believe that all cysts in their initial stages
(microcysts) are apocrine (Haagensen 1983).
Thus, whilst it is now considered that cysts arise from lobules,
their mode of formation and the nature of their precursors remains
uncertain.
Relationship to hyperplasia and breast cancer
The association of epithelial proliferation and cysts is so well
recognised that it is accepted as a component feature of cystic
disease (Azzopardi 1979, Haagensen et al 1981). Proliferation may
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take two forms: (i) increase in the number of lobular units
(adenosis); or (ii) increase in the number of cells lining the
existing lobules (hyperplasia) (Azzopardi 1979). It is hyperplasia
that has been shown to be associated with an increased risk of
breast cancer (Black et al 1972, Kodlin et al 1977, Page et al
1978), although the significance of this risk remains controversial.
Astley Cooper (1829), when he first described cysts, noted that
carcinoma could coexist in the same breast, a finding confirmed by
Brodie (1946). Early workers considered these carcinomas to be
incidental findings (Konig 1893). Tietze (1900) was the first to
regard the "adenomatous" proliferation seen in cystic disease to be
precancerous. Since then, numerous studies have attempted to
analyse the interrelationship of cystic disease, hyperplasia and
breast carcinoma.
The types of evidence relating cystic disease and carcinoma include:
(i) a, similar relationship to parity Both are more common in
nulliparous women, possibly suggesting a common aetiological factor
(Bonser et al 1961).
(ii) demonstration of the initial stages of carcinoma in cvsts or
associated hyperplasia Carcinoma can arise in the wall of a cyst,
although it is rare (Cheatle et al 1931, Bonser et al 1961).
Carcinoma may arise in apocrine epithelium (Borst 1904, Krompecher
1913, Berka 1911, Cheatle et al 1931, Dawson 1932, Lee et al 1 933,
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Ewing 1940, Geschickter 1943, Stewart 1950, Azzopardi 1979) and
about 10% of all invasive carcinomas demonstrate marked apocrine
differentiation (Bonser et al 1961, Dixon et al 1983).
(iii) incidence of cvstic disease in patients with carcinoma Where
adequate data on the incidence of cystic disease in the general
population have been considered, results from these studies have
been conflicting (Foote et al 1945, Frantz et al 1951, Bonser et al
1961, Sandison 1962, Davis et al 1964). It is accepted, however,
that there is a greater incidence of hyperplasia in breasts affected
by carcinoma, suggesting, but not proving, that such lesions may be
the precursors of malignancy.
(iv) retrospective studies Foote and Stewart (1945), in a
retrospective case control study, showed patients with breast cancer
had a 2.2 times greater incidence of a previous benign breast
biopsy.
(v) prospective studies The majority of these studies have reviewed
benign biopsies performed many years ago and the subsequent course
of patients observed. The majority suggest some increased risk of
breast cancer in patients having a biopsy for cystic disease, the
overall risk being between 1.5 and 4.5 times the expected (Warren
1940, Davis et al 1964, Donnelly et al 1975, Monson et al 1976, Page
et al 1978). These studies have indicated that it is epithelial
hyperplasia that is associated with the increased risk (Black et al
1972, Kodlin et al 1977, Page et al 1978). Haagensen (1971), in
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contrast, suggests gross cysts rather than epithelial proliferation
are the pathological feature associated with this increased risk.
In keeping with this, he has shown that patients with cysts treated
by aspiration have an increased subsequent risk of breast cancer
compared to the general population, the risk being greater in
patients who have two or more cysts (Haagensen et al 1981).
(vi) specific histological features in the breasts of patients with
cancer Wellings et al (1975) found a higher incidence of many
lesions in the breasts of patients with breast cancer. Both
Wellings (1975) and Izuo (1971) showed apocrine change and apocrine
proliferation to occur more frequently in association with breast
cancer.
In conclusion, there remains conflicting views expressed in the
literature regarding the risk of carcinoma in patients with cystic
disease. The generally held view is that there is a definite,
statistically valid, but modest increased risk in such patients
(Azzopardi 1979).
Composition of Cvst Fluids
A variety of electrolytes, proteins and hormones have been measured
in breast cyst fluids.
Electrolyte concentrations have been shown to vary widely between
individual cyst fluids (Gatsy et al 1 979, Bradlow et al 1981b,
Bradlow et al 1983b). This variation greatly exceeds that in plasma
and the concentrations of sodium and potassium range from those of
extracellular fluid ([Na+] >> [K+]) to those of intracellular fluid
([K+] > [Na+]). Attempts have been made to classify cyst fluids on
the basis of these cations (Bradlow et al 1981b, Bradlow et al
1983b, Gairard et al 1983)-
Numerous proteins in cyst fluid have been studied. The total
protein content of these fluids tends to be less than that of plasma
(Gairard et al 1983), but specific proteins occur in concentrations
greatly in excess of those in plasma. These proteins include
carcinoembryonic antigen (Fleisher et al 1974, Gairard et al 1983),
a progesterone binding protein (Pearlman et al 1973) and a series of
glycoproteins (Haagensen et al 1977, Haagensen et al 1979).
Immunoglobulins have also been measured and characterised in cyst
fluid. IgA may exist in the 7S or 1 1 S form, the predominant form
varying between individual fluids (Yap et al 1982, Yap et al 1984).
Fluids with the secretory form of IgA (11S) have been shown to have
62
higher concentrations of DHA sulphate and lower concentrations of
albumin than those with the 7S form (Yap et al 1982, Yap et al
1984).
The hormonal composition of cyst fluid has been extensively studied.
Of the peptide hormones GH, LH and FSH are usually found in lower
concentrations in cyst fluid than in plasma, whereas calcitonin,
prolactin and human chorionic gonadotrophin are present in greater
amounts in cyst fluids (Bradlow et al 1983a, Melis et al 1983).
Steroid hormones can be divided into two groups. Unconjugated
hormones such as corticosterone, progesterone, testosterone,
oestrone and oestradiol do not accumulate significantly in cyst
fluids, the median value in cyst fluids being approximately three
times that of plasma. On the other hand, androsterone,
epiandrosterone and dehydroepiandrosterone and their conjugates are
present in concentrations many times than those in plasma (Bradlow
et al 1 976, Bradlow et al 1979, Bradlow et al 1981a, Miller et al
1982, Bocuzzi et al 1983, Bradlow et al 1983a, Melis et al 1983,
Miller et al 1983). The hormone conjugate DHA sulphate may be
present in cyst fluids in amounts many hundred times its plasma
level (Miller et al 1982, Bradlow et al 1 983a). It is of note that
DHA sulphate is not similarly concentrated in cyst fluids of renal,
ovarian or hepatic origin (Bradlow et al 1983a).
Tracer studies using labelled steroids have shown that, of those
steroids present in cyst fluids in high concentration, only DHA
sulphate shows any significant accumulation in cyst fluid. These
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studies also demonstrated that neither 3^0 or 1llC antipyrene
readily enters oyst fluid, indicating that the entry of DHA sulphate
into cyst fluids must be facilitated by some mechanism such as
active transport (Bradlow et al 1983a).
Despite the variety of substances that have been measured, our
understanding of how cyst fluids form and what influences their
composition, or if the composition relates to subsequent behaviour
of cystic disease, remains ill understood.
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Studies on the Composition of Human Breast Cvst Fluid
(i) Electrolytes and DHA sulphate
(ii) Proteins and form of IgA
(iii) pH
(iv) Factors affecting composition of cyst fluid




e) length of history
(v) Correlation of concentration of DHA sulphate in breast cyst
fluid and breast secretions in the same patient
(vi) Correlation of composition of cyst fluid and frequency and
volume of breast secretions
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(i) Electrolyte and DHA sulphate concentrations in breast cvst
fluid
The aim of this study was to measure Na+, K+ and DHA sulphate in
breast fluids and to analyse their interrelationships to assess
whether it might be possible to classify cyst fluids on the basis of
these constituents.
Patients. Materials and Methods
One hundred cyst fluids were obtained by needle aspiration from 85
patients. In 75 subjects a single cyst was aspirated and in the 10,
multiple cysts were drained. Volumes aspirated varied from 0.7 to
50 ml. All 100 patients were premenopausal.
Na+ and K+ were measured by flame photometry and DHA sulphate by
radioimmunoassay.
Analysis of data was performed by the Kendall Rank or Wilcoxon Rank
sum test.
Results
The levels of Na+ and K+ in the 100 cyst fluids are shown in Figure
1. Values for both ions varied enormously and for K+, were usually
greatly in excess of the reference range for plasma. The
distribution of values about the mean for both Na+ (Figure 2) and K+
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(Figure 3) was suggestive of there being more than one population.
This was accentuated when the ratios of Na+ to K+ in the 100 cyst
fluids were examined (Figure 4).
The concentrations of DHA sulphate in each cyst fluid is shown in
Figure 5. Levels varied from 1.5 to 870 pmol/1 with a median value
of 80 pmol/1.
The interrelationships between Na+, K+ and DHA sulphate are shown in
Figures 6, 7 and 8. The relationships of Na+ to K+ and Na+ to DHA
sulphate were inverse, while K+ and DHA sulphate were directly
related. All interrelationships were significant, p < 0.001.
As the distribution of the ratios of Na+ to K+ suggested that there
were two or three separate populations of cyst fluids, the 100
fluids were arbitrarily separated into three groups on the basis of
the Ma+/K+ ratio (Figure 9). One group was of 47 fluids in which
the Na+ concentration exceeded that of K+, (K+ fluids), another of
43 fluids in which the Na+ concentration was at least three-fold
higher than that of K+ (Na+ fluids) and a further group of 10 fluids
with intermediate electrolyte values(mix cyst fluids). Values of
DHA sulphate in these subgroups were then compared (Figure 10).
Concentrations of DHA sulphate in K+ cyst fluids were significantly
higher than that in the Ma+ group (p < 0.0005). Levels in mix cysts
were similar to those in the K+ group but significantly higher than
the values in the Na+ cysts (p < 0.001).
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As the mix group was indistinguishable from the K+ group in terms of
DHA sulphate concentration, in all further analyses cyst fluids were
divided into just 2 groups - those with a low Na+/K+ ratio (<3) and
those with a high Na+/K+ ratio (^3) (Figure 11). Replotting of the


























gure 1 Concentrations of sodium
cyst fluids. Horizontal
Vertical lines represent
and potassium in human breast
lines represent mean level,










0 /.O 60 80 100 120 UO 160 180
m
200
sodium ( mmol / I )

















































plasma cyst breastfluids secretions
Figure 5 DHA-sulphate concentrations in human breast cyst fluids.
Dotted vertical lines represent range in human plasma and
breast secretions obtained by nipple aspiration. Horizontal
lines represent median values.
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Figure 9 Separation of human breast cyst fluids into 3 groups based
on Na+/K+ ratio. Lines represent arbritrary division to
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Figure 11 Separation of human breast cyst fluids into those with a


















Figure 12 DHA sulphate concentrations in the two populations of human
breast cyst fluids defined on the Na+/K+ ratio.
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(ii) Proteins and form of IgA in breast ovst fluid
Cyst fluids have been shown to contain IgA in either the secretory
(11S) or non-secretory (7 S) form and it is possible to
subdivide breast cysts into two groups on this basis (Yap et al
1982, Yap et al 1984). Albumin, lactoferrin and IgG were also
measured in the same cyst fluids and shown to vary between
individual cyst fluids. Significant differences in concentrations
of some of these substances were apparent in cyst fluids classified
according to IgA type (Yap et al 1982, Yap et al 1984). The fluids
upon which these measurements were performed were still available in
this department. The aim of this study was therefore to determine
if classification by IgA type was the same as that by electrolyte
content and also to compare the levels of albumin, lactoferrin and
IgG in the two populations of cyst fluids defined by Na+/K+ ratio.
Patients. Materials and Methods
Ninety-six fluids aspirated from 75 patients had concentrations of
IgG, albumin and lactoferrin measured by immunodiffusion and IgA and
DHA sulphate content estimated by radioimmunoassay. The IgG,
albumin, lactoferrin and IgA were measured by Dr P L Yap as part of
work for a PhD thesis (Yap 1981). These methods, therefore, will
not be presented. In the 19 cyst fluids with the highest
concentrations of IgA, the form of IgA (11S or 7S) was determined by
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sucrose density ultracentrifugation and Na+ and Ka+ were measured by
flame photometry. Results presented will be for this group of
fluids.
Statistical analysis was by the Wilcoxon Rank sum test or Fisher's
exact test.
Results
There were 9 cyst fluids with a low Na+/K+ ratio and 10 cyst fluids
with a high Na+/K+ ratio. The concentrations of DHA sulphate
IgG, albumin and lactoferrin (Figure 13) were significantly
different in the two groups (all p < 0.01, except lactoferrin p <
0.05). Concentrations of IgA were similar in both groups (Figure
14) but the predominant form in the cysts with a low Na+/K+ ratio
was the secretory (11S) form, in contrast to the group with a high
Na+/K+ ratio where the 7S form predominated (Table I). This
correlation was significant (p = 0.0001). Comparison of IgA type and
DHA sulphate concentration is shown in Figure 15 and demonstrates
that the one cyst fluid with a high Na+/K+ ratio which had




























Figure 13 Concentrations of IgG, albumin and lactoferrin in cyst












Figure 14 Concentrations of IgA in cyst fluids subdivided on the
basis of the Na+/K+ ratio. Normal range of IgA in plasma










Table I Relationship between IgA type and
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Figure 15 Concentrations of DHA sulphate in cyst fluids subdivided
on the basis of the predominant type of IgA (7s or lis).
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(iii) _pH .of Breast Cvst Fluids
The aim of the present study was to measure pH in fresh cyst fluids
to determine if differences in pH exist between the two populations
of cyst fluids defined on the ratio of Na+ to K+, and also to
determine the effect of storage of fluids on pH.
Patients. Materials and Methods
One hundred and six breast cyst fluids were aspirated from 74
patients into airtight syringes, placed on ice and pH measured
within 1 hour using a Corning 178 pH/blood gas analyser. Na+ and K+
concentrations were measured in the same fluids by flame photometry.
Ten fluids were stored at -20°C and pH was remeasured 1 week and 1
month after aspiration.
Forty-four cysts had pH estimated using Multistix reagent strips
(Ames Division, Miles Laboratories, Slough, England).
Statistical correlation of pH and Na+/K+ ratio was by the Kendall
Rank test and comparison of pH in the two populations of cysts
defined by Na+/K+ ratio was made using the Wilcoxon Rank sum test.
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Results
The pH values of the 106 cyst fluids ranged from 6.3 to 7.8 (Figure
16). There was a significant positive correlation between pH and
Na+/K+ ratio, p < 0.001 (Figure 17). Comparison of fluids
subdivided into different types according to Na+/K+ ratio (cut off
Na+/K+ <3 or ^3) showed no overlap in values between the two
populations, the difference between the groups being statistically
significant (p < 0.001) (Figure 18).
The effect of storage on pH in 10
After 1 week pH had increased in
1 month it had further increased
initial values.
cyst fluids is shown in Figure19.
all fluids by a mean of 0.4 and by
by a mean of 0.9 of a pH unit over
pH as estimated by Multistix also differed in the two groups of
fluids defined on electrolyte content (Table II). It is thus
possible to separate cyst fluids into two groups by a simple
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figure 18 pH values in the two populations of cyst fluids defined on
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(iv) Factors affecting the composition of breast cvst fluid
The aim of the present study was to determine which factors might
influence the concentrations of Na+, K+ and DHA sulphate in breast
cyst fluids. The factors studied included age of the patient,
menopausal status, parity, volume of the cyst, whether cysts were
single or multiple, whether the patient was taking the oral
contraceptive pill, and length of time the cyst had been present.
a) Age. Menopausal Status and Parity
The concentration of DHA sulphate in cyst fluid measured by
radioimmunoassay was compared with age and menopausal status in 40
patients who had 46 cysts aspirated and is shown in Figures 20 and
21. Age did not relate to DHA sulphate. Median DHAS concentrations
tended to be lower in the cysts of postmenopausal women but the
differences in the two groups did not reach statistical
significance. Parity similarly showed no significant correlation to
DHA sulphate content of cyst fluid.
b) Volume
A comparison of DHA sulphate concentrations and cyst volume for the
100 patients studied for Na+,K+ and DHA sulphate is shown in Figure








I 1 ! 1 1-
35 40 45 50 55
age - years
figure 20 Comparison of DHA sulphate concentrations in human breast














Figure 21 Comparison of DHA sulphate concentrations in human breast
cyst fluids with menopausal status of the patient. Pre¬
menopausal was defined as women who had a period within
last 3 months. Postmenopausal defined as women whose last
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figure 22 Comparison of DHA sulphate concentrations in human breast
cyst fluids with volume of the fluid aspirated.
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c) Multiplicity
In the group of 85 patients with 100 cysts, 10 patients had multiple
cysts in one or both breasts. Table III gives details of these 10
patients with the cysts classified on the basis of the Na+/K+ ratio
in cyst fluid. It is evident that in nine of the 10 patients, the
cysts each patient developed were all of the same type, ie they all
had either a low or a high Na+/K+ ratio. One patient had mixtures
of cysts. Seven of the 9 patients whose cysts were all the same
type had cysts with a low Na+/K+ ratio and two had had cysts with a
high ratio. Comparing this with the overall distribution of cysts
(57% low ratio) multiple cysts appear more likely to have a low
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Ten patients with multiple cysts with cysts classified
according to ratio of Na+ to K+.
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d) Qra,l contraceptives
A review of all patients who had cyst fluids stored on file within
this department identified only 13 patients who were taking the
combined oral contraceptive pill at the time they had their breast
cyst aspirated. All 13 patients had been on the contraceptive pill
for at least 6 months. From the data on patients who had either
previously taken the pill (on pill for at least 6 months, last taken
pill >12 months prior to cyst aspiration) or who had never been on
the pill, 2 groups of 13 patients were matched with the current pill
takers for age (within 2 years) menopausal status and parity (+1).
All cyst fluids aspirated from these 39 patients had Na+ and K+
estimated and the groups were then compared using the X2 test.
There were 16 cysts aspirated in the 13 patients in the group on the
pill, 55 cysts aspirated in the group previously on the pill and 39
cysts in the group who had never taken the pill. There were
significantly larger numbers of cysts in both the patients
previously on the pill and those never on the pill (p < 0.01 for
both). A summary of the Na+/K+ ratio in these cyst fluids is shown
in Table IV. It shows a significantly lower percentage of cyst
fluids with a low Na+/K+ ratio in the group taking the pill at the
time of cyst aspiration (p < 0.001 compared with both groups) and a
significant reduction in the number of patients with these cysts
when compared to the other two groups combined (p < 0.05).
100
Presently Previously Never on
on Pill on Pill Pill
Number of patients 13 13 13
Number of cysts 16 55 39
Number of cysts with
low Na+/K+ ratio 7 (44?) 49 (89?) 35 (90?)
high Na+/K+ ratio 964
Number of patients
with any cysts having
a low Na+/K+ ratio 4 (31?) 9 (69?) 9 (69?)
Table IV Cyst fluids subdivided into two populations on Na+/K+
ratio in the matched groups of: patients presently on the
pill; patients previously on the pill and those who had
never taken the pill.
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e) Length of history and cvst composition
It has been suggested that the cyst epithelium becomes flattened as
time since formation increases and that the colour of cyst fluid
correlates with age of the cyst (Haagensen et al 1981). A
prospective study comparing length of history of the breast mass,
electrolyte composition and cyst fluid colour was undertaken in 75
cysts aspirated from 50 patients.
Cysts were separated into three groups on the basis of colour(straw or
yellow, green and blue/black). Comparison of composition and length of
history in weeks were made between these 3 groups.
There was no correlation between length of history and composition, length
of history and colour or colour and composition. This indicates that
neither composition; nor colour are related to the length of time which a
cyst has been present.
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(v) Correlation of the concentration of DHA sulphate in breast
cvst fluid and breast secretions in the same patient
Introduction
Having identified that the concentrations of DHA sulphate vary-
widely in breast cyst fluids and breast secretions obtained by
nipple aspiration, the aim of the present study was to determine if
there was a correlation between values in individual women.
Patients. Materials and Methods
Breast secretions were obtained from one or both breasts in 10
patients on the same day they had a single breast cyst aspirated.
DHA sulphate was estimated in samples of cyst fluid and breast
secretions by. radioimmunoassay. Na+ and K+ were also measured in
cyst fluid by flame photometry. The Kendall rank test was used to
compare DHA sulphate values in the two fluids. The Wilcoxon rank
sum test was used to compare DHA sulphate levels in breast
secretions from patients who had cyst fluids with a low or high
Na+/K+ ratio.
Results
There were 18 samples of breast secretions and 10 cyst fluids
aspirated from the ten patients. Figure 23 shows a comparison of
DHA sulphate concentrations in cyst fluids and breast secretions.
The correlation coefficient for this comparison was -0.22,
indicating no significant correlation between values of DHA sulphate
in those two fluids when aspirated on the same day from individual
patients.
Six cyst fluids had a low Na+/K+ ratio and four had a high Na+/K+
ratio. DHA sulphate levels in breast secretions in the two groups
subdivided on Na+/K+ ratio in cyst fluid are shown in Figure 24.
There was no significant difference in DHA sulphate concentrations
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Figure 23 Comparison of DHA sulphate concentrations in cyst fluids
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(vi) Correlation of composition of cvst fluid and
frequency and volume of breast secretions
Introduction
Cysts with a low Na+/K+ ratio contain active secretory products (11S
IgA and lactoferrin) and it may be that they arise in breasts with a
greater degree of secretory activity. The aim of the present study
was to compare the frequency with which breast secretions are
obtained from women with cysts having either a high or low Na+/K+
ratio and to compare the volumes obtained in the two groups.
Patients. Materials and Methods
From data on file for over 1 ,000 women, from whom it has been
attempted to obtain breast secretions, two groups of women were
identified: 21 non-secretors and 32 secretors who had a history of
cyst aspiration on the same date that an attempt was made to obtain
secretions by nipple aspiration. Na+ and K+ were estimated in all
cyst fluids from these patients by flame photometry and then a
comparison of the frequency and volumes of secretion obtained in
women with the two types of cyst performed using the and Wilcoxon
rank sum tests respectively.
Results
Eighteen non-seeretors and 30 secretors had cysts aspirated which
were all of one or other type, ie all cysts had a low or high Na+/K+
ratio. The remaining 5 patients had mixtures of the two cyst types.
Overall, 19 had cysts with low Na/K+ ratios and from 11 secretions
were obtained (58?); 29 had cysts with high Na+/K+ ratios and
secretions were obtained in 19 (66?). There was no significant
difference in the frequency of obtaining breast secretions from
either group.
From the 11 secretors with cysts having a low Na+/K+ ratio,
secretions were obtained from both breasts in 9 (82?). In contrast,
secretions were obtained from both breasts in only 8 of the 19 (42?)
women whose cysts had a high Na+/K+ ratio. This difference was
significant, p < 0.05.
The total volume of secretion from both breasts in each patient was
calculated and then the volumes of secretion in women whose cysts
had either high or low Na+/K+ ratios compared as shown in Figure 25.
The volumes of secretion in the group of patients with cysts with a
low ratio were significantly higher (median volume 12.8 }il) than in
patients with cysts having a low Na+/K+ ratio (median volume 4.4
/il), p < 0.02.
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Although patients with active secretory cysts (IIS IgA low Na+/K+
ratio) are not associated with an increased frequency in obtaining
breast secretions, they are associated with a greater likelihood of
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Figure 25 Volumes of breast secretions obtained from patients with
breast cysts subdivided according to the Na+/K+ ratio in
the aspirated cyst fluid
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DISCUSSION
These studies confirm the wide variation in levels of Na+, K+ and
DHA sulphate in breast cyst fluids (Bradlow et al 1981a, Bradlow et
al 1981b, Miller et al 1982, Bradlow et al 1983a, Bradlow et al
1983b, Miller et al 1983). They further show significant
associations between the concentrations of these three constituents.
As has been previously noted, the levels of Na+ and Ka+ in cyst
fluids are not normally distributed around their mean values,
suggesting that there may be more than one population of cyst fluids
(Bradlow et al 1981b). Using the relative concentrations of Na+ and
K+, it has been possible to define two populations of cyst fluids, a
classification which also subdivides cyst fluids in those with high
or low levels of DHA sulphate.
Cyst fluids have been previously classified into two groups on the
basis of the predominant form of IgA present in the fluid (Yap et al
1982). A comparison of 19 cyst fluids subdivided on the basis of
Na+/K+ ratio was almost identical to that based on the predominant
form of IgA. Cyst fluids with a low Na+/K+ ratio were shown to have
predominantly (secretory) 11S IgA, whereas those with a high ratio
had 7S (non-secretory) IgA. There was, however, one fluid which
differed in the two classifications, a cyst with a high Na+/K+ ratio
which had predominantly secretory IgA. This contained low levels of
DHA sulphate, indicating that the cyst fluid was more likely to be
of non-secretory type, suggesting that it was correctly classified on
the basis of electrolyte composition but not IgA type. Cyst fluids
with a low Na+/K+ ratio in addition to having secretory IgA, also
contain higher concentrations of a further secretory product
lactoferrin, whereas cysts with a high Ne?/K+ ratio contain the 7S
form of IgA and greater amounts of albumin and IgG and thus more
closely resemble the composition of plasma.
Human breast cyst fluids have been previously reported to be
alkaline, with a pH range of 7.6 - 9.0 (Gatsy et al 1979). These
measurements were, however, performed on stored samples and this
study has shown that fresh cyst fluids are acidic or neutral and
only become alkaline on storage. This finding of a change in pH may
have more important implications when interpreting data on enzymatic
activity in stored cyst fluid, as activity is known to change with
pH (Schwartz et al 1976).
Having identified two populations of cyst fluids, it remains to
establish how these two fluids are derived. There exists two
possibilities:
(i) there may be differences in the secretory activity of the
epithelium from which these fluids are derived, or
(ii) the fluids in the two groups of cysts may be derived from
different sources, namely plasma and breast.
The composition of cyst fluids with a high Na+/K+ ratio is similar
to that of plasma (Table V). Although DHA sulphate levels in cyst
fluids with a low Na+/K+ ratio are similar to those in breast
secretions obtained by nipple aspiration, Na+ is the predominant ion
in these secretions (Table V). Also, in any one patient, there was
no apparent relationship between DHA sulphate levels in secretions
and cyst fluids, even for the fluids which may be breast derived.
Simple accumulation of secretions is therefore unlikely to account
for the formation of these cyst fluids.
It seems more likely that the two fluids may arise from epithelium
with differences in secretory activity. Certain cysts are known to
be lined by apocrine secretory epithelium (Azzopardi 1979) and it is
known that apocrine secretions from other sites in the body contain
high concentrations of DHA sulphate (Labows et al 1979). Apocrine
secretion occurs by the expulsion of intracellular secretory
granules (Azzopardi 1979). Intracellular fluid has a lower pH
than extracellular fluid (Waddell et al 1969) and apocrine secretion
from the axilla is known to be acidic (Hurley et al 1960). The
findings of active secretory products (IIS IgA and lactoferrin) and
a low pH in cyst fluids with a low Na+/K+ ratio would thus be
consistent with fluids derived from apocrine epithelium. In
contrast, those fluids with a high Na+/K+ ratio which have been
previously noted to resemble plasma in composition may be derived
























































































It might be expected that the secretory activity of breasts in which
active secretory cysts arise might be greater than that of breasts
in which inactive cysts arise. The frequency of obtaining breast
secretions from both groups of patients were similar, but secretions
were more commonly obtained from both breasts and the total volumes
of secretions obtained were greater in patients with cysts with a
low Na+/K+, suggesting that in those women who do produce
secretions, greater amounts of secretion may be produced in patients
with active secretory cysts.
Neither population of cysts was more frequent in any age group and
their occurrence did not differ in pre and postmenopausal women.
Volume was also unrelated to composition. This latter finding
indicates that an active secretory cyst probably does not become
less active when it becomes larger. The observation that there is
no correlation between the length of time a cyst has been present
and composition also suggests that there is no transition from one
type of cyst to another. Further support for this comes from the
finding that multiple simultaneous cysts in any one woman tend to be
of the same type. Thus, there may be a factor which determines
whether a patient develops cysts of one or other type. The patients
with multiple cysts were also noted to have a higher frequency of
cysts with low Na+/K+ ratios. It may be then that the composition
of cyst fluids relates to subsequent behaviour and the natural
history of cystic disease.
Long-term use of the oral contraceptives has been reported to be
associated with a diminished occurrence of cystic breast disease
(Vessey et al 1972, Boston Collaborative Drug Surveillance Programme
1973, Sartwell et al 1973, Kelsey et al 1974, Fasal et al 1975, Ory
et al 1976, Cole 1977, Royal College of General Practitioners 1977,
Lee et al 1978, Pastides et al 1983)- Only 13 women from a series
of over 600 were identified in the present study who were taking
oral contraceptives at the time they developed a cyst. These women
had significantly less cysts than matched groups of women who had
either previously taken the oral contraceptive or had never taken
it. This supports the finding in biopsies of women taking the
contraceptive pill which have shown less gross cysts in these
subjects (Pastides et al 1983). There was no reduction in the
number of cysts aspirated from women who had previously taken the
pill. It has been reported that the protective effect of the oral
contraceptive agent in reducing benign breast disease carries on for
many years after use (Cole 1977). It may be, however, that the
length of time which had passed since their use was too great to see
this effect in the present study.
The cysts in women on the pill appear to be less likely to contain
fluid with a low Na+/K+ ratio. If, as has been proposed, this
population of cysts is derived from apocrine epithelium, then it is
of relevance (i) that the oral contraceptive is known to reduce
secretion from the apocrine ceruminal glands of the external ear
(Royal College of General Practitioners 1974) and (ii) that the pill
has also been shown to reduce the frequency of apocrine change in
the breast as assessed by breast biopsy (Pastides et al 1983). In
this department it has also been shown that, contrary to the initial
studies of Petrakis et al (1975), the pill reduces the frequency of
fluid obtained by nipple aspiration from non-pregnant women. The
contraceptive pill may therefore reduce the secretory activity of
the breast with a resultant decrease in the frequency of active
secretory cysts.
In summary, two populations of cyst fluids can be defined on the
basis of composition and these may be derived from different types
of epithelium. The oral contraceptive reduces the number of cysts
in patients, probably by reducing secretory activity in the breast
The clinical relevance of these two populations remains to be
investigated.
Studies on breast cvst epithelium
(i) The relationship between epithelial lining and composition of
breast cysts
(ii) Electron microscopy studies of breast cyst epithelium
(iii) Peroxidase localisation of DHA sulphate in breast cyst
epithelium
The relationship between epithelial lining and composition of breast
cvsts
Introduction
Previous studies have shown human breast cysts can be separated into
two populations on the basis of the relative concentrations of Na+
and K+ in cyst fluid. One possible explanation is that the two cyst
fluids may originate from different types of epithelium. The aim of
this study wa3 to investigate the relationship between the
morphology of the epithelium lining human breast cysts and the
content of cyst fluid.
Materials and Methods
Morphological assessment of the epithelium lining 40 human breast
cysts was performed either by:
(i) centrifuging an aliquot of cyst fluid and examining the stained
deposit cytologically (26 cysts from 22 patients), or
(ii) dissecting cysts from tissue obtained at mastectomy or biopsy,
aspirating the cyst fluid and submitting the cyst wall for
histological processing and serial sectioning (7 cysts from 6
mastectomy specimens and 7 cysts from 6 biopsy specimens).
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The aspirates of cyst fluid were stained by Papanicolaou's technique
(Pap) and by periodic acid Schiff after diastase digestion (PAS
diastase). Dissected cyst specimens were stained by haematoxylin
and eosin (H & E) and PAS diastase. PAS diastase positive granules
in the cytoplasm of cells were used as a positive method of
identification of apocrine epithelium (Azzopardi 1979). All cyst
fluid aspirates and dissection specimens were assessed by a
consultant pathologist with a specific training in breast histology
and cytology.
The concentrations of Na+ and K+ in the 40 cyst fluids were measured
by flame photometry and DHA sulphate was measured by
radioimmunoassay.
It was possible to identify two major types of epithelial cells in
both cytological and dissection preparations.
(i) acidophilic cells (on H & E) with copious granular cytoplasm
containing PAS diastase positive granules, luminal apical
snouts (seen in histological preparations only) and nuclei
showing prominent nucleoli - APOCRINE epithelium;
(ii) basophilic cells (on H & E) having less cytoplasm and
containing no PAS diastase positive granules FLATTENED
epithelium.
Results
Figures 1 and 2 show examples of apocrine and flattened epithelium
in breast cyst aspirates. Figure 3 shows the specific glycolipid
granules in the cytoplasm of apocrine cells. Figures 4 and 5
demonstrate apocrine and flattened epithelium in dissection
specimens and Figures 6 and 7 show PAS diastase stained sections of
the two types of epithelium.
In this series, no cyst showed a mixture of apocrine and flattened
epithelium in either aspiration or dissection specimens. In 22
cysts the lining was assessed as apocrine (14 by aspiration and 8 by
dissection) and in 18 the lining was flattened epithelium (12 by
aspiration and 6 by dissection).
The relationship between the morphology of the lining epithelium as
assessed in cytological and dissection specimens and the ratio of
Na+ to K+ is shown in Figure 8. Cysts lined by flattened epithelium
all had a higher Na+/K+ ratio than cysts lined by apocrine
epithelium, the difference in ratios being significant (p < 0.001
Wilcoxon's rank sum test). On the basis of the Na+/K+ ratio, it was
thus possible to distinguish completely between apocrine and
flattened epithelial cysts.
The DHA sulphate concentrations in cysts lined by the two types of
epithelium are shown in Figure 9. The concentrations in the two
groups was statistically significant with no overlap of values
(p < 0.001 Wilcoxon's rank sum test).
Figure 1 Cytological preparation of a cyst aspirate showing apocrine
cells. The cells have copious pale cytoplasm with vesicular
nuclei showing prominent nucleoli (Pap x 400)
Figure 2 Cytological preparation of a cyst aspirate showing simple
flattened epithelium. The cells have small amounts of cyto¬
plasm, deeply staining nuclei and no special features
(Pap x 400)
Figure 3 Cytological preparation of a cyst aspirate stained to show the
specific glycolipid granules found in apocrine cells. The
vesicular nuclei with prominent nucleoli also a feature of
apocrine epithelium are easily seen (PAS diastase x 300)
122
I
Figure 4 Dissection specimen of an apocrine cyst. The cells are
columnar and have basally situated nuclei, abundant
cytoplasm and apical snouts containing deeply staining
intracytoplasmic glycolipid granules (H & E x 200)
/
Figure 5 Dissection specimen of a flattened epithelial cyst.
The epithelium is attenuated and flattened and few
cells are visible in any one section (H & E x 400)
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Figure 6 Dissection specimen showing the apical position of
the glycolipid granules in apocrine epithelium
(PAS diastase x 300)
Figure 7 Dissection specimen showing flattened epithelium stained
to show glycolipid granules. Note the absence of any
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Figure 8 The ratios of Na+ to K+ in cysts where the epithelium was
assessed as apocrine or flattened by








Figure 9 DHA sulphate concentrations in cyst fluids where the
lining epithelium was assessed as apocrine or flattened.
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(ii) Electron microscopy studies of breast cvst epithelium
The aim of this study was to compare and contrast the
ultrastructural features of apocrine and flattened epithelium lining
human breast cysts.
Patients. Materials and Methods
Biopsies from patients with cysts were processed as previously
described and viewed by electron microscopy.
Results
Cysts lined by apocrine and flattened epithelium were identified.
The main ultrastructural features of these two types of epithelium
are outlined below.
Apocrine epithelium
The basally situated rounded nuclei with prominent nucleoli, and the
apical snouts noted on light microscopy were more easily seen
(Figure 10). The cytoplasm was rich in organelles with large
numbers of mitochondria (Figure 11). The apical plasma membrane was
lined by microvilli and below this, the apical cytoplasm contained
membrane bound electron dense vesicles (Figure 12).
Flattened epithelium
The cells were elongated and attenuated and contained few
organelles. There were few mitochondria and no membrane bound
vesicles (Figure 13).
x 5,800
Figure 10 Electron microscopy of apocrine epithelium. The regular
nuclei with prominent nucleoli and the cytoplasm rich in
organelles are easily seen (x 5,800)
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Figure 11 Electron microscopy of apocrine epithelium. Note the
bulbous apical margins and the subapical electron dense
intracytoplasmic granules (x 5,800)
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Figure 12 Electron microscopy of apocrine epithelium to demonstrate
the microvilli and dense subapical granules (x 13,000)
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Figure 13 Electron microscopy of flattened epithelium. The cells
are elongated, have no special features, no granules and
no microvilli. A layer of myoepithelial cells is present
beneath the flattened epithelium (x 20,000)
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(iii) Peroxidase localisation of DHA sulphate in breast cvst
epithelium
Introduction
Having identified that the two populations of cysts are lined by
different types of epithelium and having previously shown
differences in DHA sulphate concentrations in cyst fluids associated
with these two types of epithelium, the aim of the present study was
to determine if there were differences in the presence of this
androgen conjugate in apocrine and flattened epithelium.
Materials and Methods
The material examined included:
(i) Frozen sections of biopsy and mastectomy material containing
breast cysts (16 different portions of tissue from 10 different
patients)
(ii) air dried cytological aspirates of breast cyst fluid (4 cyst
fluids from 4 patients)
(iii) air dried cytological smears of apocrine epithelium (6 smears
from 6 patients)
Figure 14 Preparation to demonstrate the presence of acid phosphatase
a lysosomal enzyme in apocrine epithelium. The red colour
represents the acid phosphatase activity which is greatest
at the luminal aspect of the cell (x 200).
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Results
Problems were encountered with the frozen section material. The
epithelium lining the cyst was frequently difficult to section and
either underwent lysis or floated off the slide during the
performance of the peroxidase technique. This was particularly
evident in apocrine epithelium which is known to contain high
concentrations of lysosomal enzymes as demonstrated in Figure 14.
To obtain satisfactory results on the cytological deposits from
cysts and from smears, the cells had to be frozen at -20°C before
applying the primary antibody.
It was, however, evident that apocrine epithelium in smears or
aspirates from cysts contained large amounts of material cross-
reacting with the antibody (Figures 15-17). This was diffusely
distributed in the cytoplasm, but occasionally was more prominent in
the supranuclear portions of the cells and appeared granular. In
contrast, normal epithelial cells (Figure 18), other tissues in the
sections and the cells lining flattened cysts (Figures 19 and 20)
showed little or no evidence of staining by this technique.
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^Figure 15 Frozen section of apocrine epithelium stained to show
the presence of DHA sulphate by the immunoperoxidase
stain (x 200)
Figure 16 Apocrine epithelium from a breast cyst stained for DHA
sulphate (cytocentrifuge preparation x 400)
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Figure 17 Apocrine epithelium in a fine needle aspirate specimen
stained for DHA sulphate (x 400)
Figure 18 Normal epithelial cells in a smear stained for DHA
sulphate. Note the lack of staining (x 400)
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-Figure 19 Flattened epithelium stained for DHA sulphate, little
or no staining is evident (frozen section x 200)
Figure 20 Flattened epithelial cells in a cyst aspirate stained
for DHA sulphate (cytocentrifuge preparation x 400)
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DISCUSSION
The two major populations of cysts which can be defined on the basis
of the relative concentrations of Na+ and K+ are lined by different
types of epithelium. One group of cysts is lined by apocrine
epithelium and cyst fluid derived from this epithelium has been
shown to contain high concentrations of K+ and DHA sulphate. It is
of note that apocrine secretions from axillary skin have high
concentrations of DHA sulphate (Labows et al 1979). Apocrine
sweat is also known to vary in colour from yellow to green to blue-
black (Hurley et al 1960), a similar colour range to that seen in
cyst fluids. The other group of cysts is lined by flattened
epithelium and, as previously noted, has a composition which more
closely resembles that of plasma.
Apocrine epithelium has been shown to have a high content of
oxidative enzymes (Ahmed et al 1975). The large numbers of
mitochondria present in the cytoplasm of apocrine cells is
consistent with this. The presence of vacuoles beneath the luminal
surface of these cells suggests that the material in these may be
expelled into the lumen. This type of activity indicates merocrine
rather than apocrine secretion, the latter occurring by budding off
apical cytoplasm. These observations and interpretations have also
been made by others (Pier et al 1970, Ahmed 1975, Ahmed 1979,
Azzopardi 1979). It has also been noted in ultrastructural studies
that there are prominent blood vessels adjacent to apocrine
epithelium (Ahmed et al 1975). All these observations suggest that
apocrine epithelium is very active and secretory and correlates well
with the findings of high concentrations of secretory products in
cyst fluid derived from this epithelium. These findings are
inconsistent with the view of Dawson (1932) that apocrine cells
arise by the result of degeneration and those of Bonser et al (1961)
who consider that apocrine epithelium occurs in areas with a poor
blood supply. In marked contrast to apocrine epithelium,
ultrastructural studies of flattened epithelium showed few
organelles and no introcytoplasmic secretory granules.
This study has also demonstrated that high concentrations of
androgen conjugates are present within the cytoplasm of apocrine
epithelium and this correlates well with the findings of high levels
in cyst fluid derived from this epithelium. The distribution of DHA
sulphate is rather granular in the cytoplasm of these cells and
appears in a similar distribution to the glycolipid granules
detected by the PAS diastase technique. It has been shown that
labelled DHA sulphate in blood is concentrated in cyst fluid and it
may be that this is transported across the cell in these granules
(Bradlow et al 1983a). Such active concentration would require
large amounts of energy which the mitochondria in the cell could
furnish.
The presence of DHA sulphate in apocrine cyst fluid, axillary
apocrine sweat glands and the cytoplasm of apocrine epithelium in
the breast indicates that this compound may be a marker of apocrine
activity. Petrakis (1977) has suggested a link between apocrine
activity and breast cancer; the higher the activity, the greater the
incidence of breast cancer. Other authors have also shown that
apocrine change in the breast occurs more frequently in patients at
risk of breast cancer (Wellings et al 1975, Haagensen et al 1979,
Schuerch et al 1982, Roberts et al 1984). The measurement of DHA
sulphate or of electrolytes in cyst fluid which both indicate
the presence of apocrine activity in the lining epithelium ,may
therefore be helpful in identifying patients at increased risk of
breast cancer.
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Relationship of composition of breast cvst fluid and cvst epithelial
lining to behaviour
(i) in relation to the natural history of cystic disease
(ii) in relation to hyperplasia
(iii) in relation to breast carcinoma
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(i) Relationship of composition of breast cvst fluid and epithelial
lining to the natural history of cvstio disease
Introduction
Some 7% of all women develop a palpable breast cyst (Haagensen et al
1981). It is known that about half of all women who present with
cystic disease have a single cyst, a third of patients develop
between 2 and 5 cysts and the remainder have in excess of 5
(Haagensen et al 1981). No factor is known which determines whether
a patient will develop a single or multiple cysts. The aim of the
present study was to determine if there are differences in natural
history of the two cyst types defined on electrolyte composition of
cyst fluid and cyst epithelial lining.
A prospective analysis has been carried out of 100 consecutive
patients presenting for the first time with a breast cyst and
followed over at least a 2 year period. All cysts aspirated from
these 100 patients were classified on the basis of the Na+/K+ ratio
in cyst fluid as apocrine if Na+/K+ < 3 or flattened if Na+/K+ >,
Statistical comparison of groups was by the test.
Patients
RESULTS
Of the 100 patients, 45 had only 1 cyst, 46 developed between 2 and
5 cysts and 9 had in excess of 5. There were a total of 247 cysts
aspirated during the period of follow-up, 177 of which were
classified as apocrine and 70 as flattened. Forty-three patients
developed single or multiple cysts of flattened type, 44 patients
developed single or multiple cysts of apocrine type and 13 patients
had mixtures of the two types of cysts.
Table I shows the percentage of cysts which were classified as
apocrine and flattened in patients with 1, 2-5 and > 5 cysts. It can
be seen that patients with a single cyst were more likely to have a
flattened cyst and, as the number of cysts aspirated per patient
increased, so the proportion of apocrine cysts also increased. This
is more clearly illustrated when the ratio of apocrine:flattened
cysts is plotted for the groups with varying numbers of cysts as in
Figure 1.
There were 56 episodes where patients had multiple simultaneous
cysts and in 48 (88?), all cysts were of the same type, ie all
apocrine or all flattened. Forty-three patients developed
sequential cysts and in 32 (74?) of these, all cysts aspirated over
the two year period were of the same type. Thus, individual
patients who have multiple cysts, whether they are simultaneous or
sequential usually develop cysts of one or other type. From the
Number of Number of % of cysts which were
cysts patients Apocrine Flattened
aspirated
1 45 24 76
2-5 46 75 25
>5 9 94 6
Table I Comparison of the % of cysts which were classified as
apocrine or flattened on the basis of electrolyte
composition in groups of patients who had totals of 1, 2-5
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Figure 1 Ratio of apocrine: flattened cysts in the groups of
patients who had 1, 2, 3, 4 & 5 and >5 cysts aspirated
over the follow-up period
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data presented above, it is also evident that this type is much
more likely to be apocrine.
Sixty-nine patients originally presented with a single cyst, 30 of
which were classified as apocrine and 39 as flattened; 24 patients
developed further cysts, 19 of the 30 (63%) with apocrine and 5 of
the 39 (13$) with flattened cysts. The difference between further
cysts in the two groups was highly significant (p < 0.0005).
Overall 14$ of those presenting initially with flattened cysts,
72$ of those presenting with apocrine cysts and 50$ of those with
mixtures of apocrine and flattened cysts went on to develop further
cysts (Table II). Thus, patients presenting with apocrine cysts
were more than 5 times more likely to develop a further cyst than
those with flattened cysts. Of the patients who developed further
cysts, 85$ of the patients who initially had apocrine and 50$ of the
patients who originally had flattened cysts developed subsequent
apocrine cysts.
There therefore appears to be great differences in the subsequent











All flattened 47 14?
All apocrine 47 34 72?
Mixtures of 2
types 50?
Table II Comparison of numbers of patients who developed further
cysts during a two year follow-up in the groups who
initially presented with either all flattened, all
apocrine or mixtures of the two types of cysts.
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(ii) Relationship of epithelial lining of breast cvsts to
hyperplasia
Introduction
Epithelial hyperplasia is a component part of cystic disease and has
been shown to be one of the main factors associated with the
increased risk of breast cancer in this group of patients (Kern et
al 1 969, Steinhoff et al 1970, Black et al 1972, Kodlin et al 1977,
Page et al 1978, Azzopardi 1979, Roberts et al 1984). This finding
comes from pathological studies of biopsies performed in patients
with cystic disease, but the majority of women with this condition
are never biopsied and are treated by simple aspiration (Haagensen
et al 1981). It remains uncertain which of these women are at risk
of breast cancer. The aim of the present study was to compare the
frequency and degree of hyperplasia in the groups of patients with
apocrine and flattened cysts.
Patients. Materials and Methods
During the early 1960's, it was practice in Edinburgh to biopsy all
breast lumps. From the years 1 966 and 1967 all patients who were
considered clinically to have a palpable cyst and who underwent
biopsy were identified and the histology of all of these biopsies
reviewed. The lining epithelium of any macrocysts (> 3 mm) was
recorded, as were any pathological changes in the surrounding breast
tissue. Particular attention was paid to the presence and numbers
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of any microcysts, the presence of foci of apocrine change and
papillary apocrine change, adenosis and any hyperplasia.
Hyperplasia, when present, was assessed on a 5 point scale using
similar criteria to that of Wellings et al (1975). Grade I normal,
II minimal or moderate hyperplasia, III severe hyperplasia, IV
hyperplasia with atypia and V carcinoma in situ.
Statistical analysis comparing the frequency of pathological
features in the two groups was by either the Wilcoxon rank sum or
the test.
One hundred and sixteen patients underwent biopsy for a single or
multiple breast cysts during 1966 and 1967 in the Royal Infirmary of
Edinburgh. Eighty of these had a total of 183 apocrine cysts, 30
had 38 flattened cysts and 6 patients had mixtures of the two types
of cysts. There were thus an average 2.3 macrocysts per patient in
the group with apocrine cysts, significantly more than the 1.3
macrocysts per patient in the group with flattened cysts, p <
0.0005.
A summary of the pathological changes in the biopsy specimens from
the 110 patients who had all macrocysts lined by either only
apocrine or only flattened epithelium is presented in Table III.
Microcysts, papillary apocrine change and hyperplasia were all































































































Hyperplasia of a severe degree (Grade III) or with atypia (Grade IV)
were only seen in patients with apocrine cysts.
Thus, patients with apocrine cysts are more likely to have in their
breasts a variety of other pathological changes which includes both
papillary apocrine change and epithelial hyperplasia.
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(iii) Relationship of breast ovst fluid composition and cvst
epithelial lining to breast cancer
Introduction
It is well recognised that breast cancer may develop in patients
with cystic disease (Haagensen et al 1981). No study has, however,
studied the composition of cysts or the nature of the epithelium in
cyst fluid aspirated from women who have later developed breast
cancer. It has been practice in this department for a number of
years either to send cyst fluid for cytology or to store cyst fluid
for later analysis. The aim of the present study was to classify
those cysts aspirated from patients who, at a later date, developed
breast cancer.
Patients. Materials and Methods
From a review of 400 patients who developed breast cancer, 11
patients were identified who had a history of cyst aspiration and
where all cysts aspirated could be classified either on the basis of
cytology (5 patients) or electrolyte composition (6 patients) as
apocrine or flattened. The ratio of apocrine : flattened cysts in
this group of women has been compared with that from the series of
100 patients followed over 2 years using the X2 test.
Results
The 11 patients had 24 eysts aspirated. Three of these had only a
single eyst, 5 had 2 oysts aspirated, 1 had 3 and 2 developed 4
cysts. Ten patients had single or multiple apocrine cysts and 1
patient had a single flattened cyst. This ratio of 10:1
apocrine:flatten.ed compares with the ratio of 44:43 in the series
of 100 patients presented earlier. These ratios are significantly
different (p < 0.02) and this indicates that patients with breast
cancer are more likely to have had apocrine rather than flattened
cysts and suggests that breast cancer may develop more commonly in
patients with apocrine cysts.
DISCUSSION
Two populations of human breast cysts have been identified. These
are lined by either apocrine or flattened epithelium and differ in
electrolyte composition of contained cyst fluid. The present study
has shown that these two types of cysts are associated with
differences in natural history, association with risk factors for
breast cancer and the development of breast cancer.
It has been shown that cysts lined by apocrine epithelium contain
high concentrations of secretory products indicating an active
epithelium. Patients with these active cysts are more than 5 times
more likely to develop further cysts than those with cysts lined
with flattened (inactive) epithelium. It therefore seems likely
that activity of lining may be an important factor in cyst
formation. It is of interest that, although multiple cysts are much
more likely to be apocrine, multiple flattened cysts do occur and
only a minority actually develop mixtures of the two types of cysts.
Thus, there appears to be a factor in each patient which determines
whether she will develop cysts lined by flattened or apocrine
epithelium.
Patients with greater than 5 cysts have almost exclusively apocrine
cystic disease. A number of treatments have been tried to reduce
the frequency of cysts in these patients without great success.
From this study, it is apparent that an agent which reduces apocrine
secretory activity may reduce the frequency of cyst formation. The
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oral contraceptive has been reported to reduce apocrine secretion
(Royal College of General Practitioners 1974). Earlier studies
reported in this thesis showed that patients taking the oral
contraceptive at the time of developing a cyst were (i) less likely
to have an apocrine cyst, and (ii) significantly less likely to
develop further cysts. Other drugs capable of reducing apocrine
secretion may therefore prove of use in the treatment of recurrent
breast cysts.
It has been suggested that women with cystic disease are at
increased risk of subsequent breast cancer (Azzopardi 19 T 9»
Haagensen et al 1981). The factors which have been associated with
this increased risk include hyperplasia, epithelial atypia and
papillary apocrine change (Kern et al 1969, Steinhoff et al 1970,
Black et al 1972, Monson et al 1976, Kodlin et al 1977, Page et al
1978, Azzopardi 1979, Haagensen et al 1981, Roberts et al 1984).
This study has clearly shown that all of these changes are
significantly more common in patients with apocrine cysts when
compared to those with cysts lined by flattened epithelium. Other
workers have also noted this association of apocrine epithelium and
hyperplasia (Foote et al 1945, Wellings et al 1975, Haagensen et al
1981, Vilanova et al 1983).
In keeping with this association of risk factors for breast cancer
and apocrine cysts, this study has also shown that patients with
breast cancer are more likely to have had apocrine rather than
flattened cysts aspirated prior to presenting with cancer. It is of
interest in this regard that, in populations which have a high
frequency of breast cancer, apocrine change within the breast is
more common than in populations with a low risk (Schuerch et al
1982). As the incidence of apocrine change varies in different
parts of the world, the proportion of apocrine and flattened cysts
may also vary and this may account for some of the geographical
variation of incidence of breast carcinoma. It has also been
reported that women with gross cysts who have histological evidence
of apocrine change are more than 1 1 times more likely to develop
breast cancer than those women with cysts with no histological
evidence of apocrine change (Haagensen et al 1981). It is also
relevant that it is those women who have more than one cyst
aspirated who may be at increased risk of breast cancer (Haagensen
et al 1981). This study shows that these women are likely to have
apocrine cystic disease.
It is important to point out that the findings of the present study
in relation to breast cancer can only be compared with those of
Haagensen (1971> 1981). This is the only other data relating breast
cancer to cystic disease treated by aspiration. All other reports
relate to the histological studies of biopsy material but, as the
majority of patients with cystic disease are not biopsied, the
findings of these studies are therefore not directly comparable.
The natural history of breast cystic disease and risk of subsequent
breast cancer appears directly related to whether the patient
develops cysts lined by apocrine or flattened epithelium. The
majority of women with flattened cysts have only a single cyst and
appear at little risk of breast cancer, whereas those women with
apocrine cysts tend to have multiple cysts and appear at a
relatively increased risk of breast cancer.
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Origin of Cysts
(i) Studies on the composition of human breast microcysts
(ii) Histological and ultrastructural studies of microcyst
epithelium




Clinically palpable breast cysts appear to be derived by microcysts
(< 0.3cm) (Haagensen et al 1981, Schwartz 1983) which arise from
breast lobules (Wellings et al 1975, Wellings 1980). Two
populations of human breast macrocysts have been identified and
these differ in electrolyte and hormonal composition. Little,
however, is known of the content of human breast microcysts and, in
particular, it is not known if there exists a single or dual
populations. The aim of this study was to analyse the content of
human breast microcysts.
Patients. Materials and Methods
Forty breast microcysts were dissected from 8 biopsy and 14
mastectomy specimens prior to fixation using a dissecting
microscope. Figure 1 shows a microcyst in a gross biopsy specimen.
Figures 2 and 3 show a microcyst in situ and after dissection as
seen through the dissecting microscope. The fluid within the
microcysts were collected after puncture into calibrated capillary
tubes (Figure 4). The volume of microcyst fluid was calculated
(range 0.5 - 20 _^1) by measuring the length of sample in the
capillary tube. The fluid was then diluted to 1 00 y.1 in distilled
water and stored at -40°C for later analysis.
I 1 2
MILLIMETRE
Pigure 1 A microcyst in a gross biopsy specimen
Figure 3 A microcyst after removal of fluid (x 20)
Figure 4 Microcyst fluid collected in a capillary tube (x 20)
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DHA sulphate was estimated in all 40 mierocysts by radioimmunoassay.
Na+ and K+ concentrations were measured in the 10 cyst fluids where
sufficient fluid was available (> 10 jil) by flame photometry.
The concentration of DHA sulphate in fluids from the 40 microcysts
is shown in Figure 5. For comparison, data are included on the
ranges and median values of DHA sulphate in plasma and fluid from
macrocysts lined by apocrine and flattened epithelium. All
microcyst fluids contained levels of DHA sulphate at least 10 times
greater than the upper limit of normal for plasma and the median
value was almost 1 000 times greater than that in plasma. Fluids
from more than half the microcysts contained concentrations of DHA
sulphate greater than that seen in any macrocysts. All microcysts
also contained DHA sulphate concentrations higher than the range of
fluids from cysts lined by flattened epithelium.
All 10 microcysts contained concentrations of K+ in excess of those
of Na+. The Na+/K+ ratio of the 10 microcysts in which electrolyte
composition was estimated is compared with that of the ratio in
apocrine and flattened epithelial macrocysts in Figure 6. All 10












Figure 5 Concentration of DHA sulphate in breast microcyst fluid.
Horizontal bar represents median value. The ranges and
median values for the DHA sulphate concentrations of

















figure 6 The Na+/K+ ratio in microcyst fluid. The range of ratios
for apocrine and flattened macrocysts are included for
comparison
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(ii) Histological and ultrastructural studies of microcvst
epithelium
The aim of this study was to determine the nature of the epithelium
lining breast microcysts.
Materials and Methods
The 40 microcysts from which fluid was removed were fixed in
10^ formalin solution, histologically processed and serial sections
cut and stained by H and E and PAS diastase techniques. PAS
diastase positive granules within the epithelium lining the
microcysts was used as a positive method of identifying apocrine
epithelium (Azzopardi 1979).
Microcysts in 2 biopsy and 2 mastectomy specimens were examined by
electron microscopy. A total of 20 microcysts were studied.
All 40 microcysts were lined by epithelium which showed apocrine
features. Many showed columnar epithelium with apical snouts
(Figure 7) but, in others, the epithelium was more cuboidal. All
contained, to some degree, PAS diastase positive granules at the
luminal margins of the lining epithelium (Figure 8).
Results
Figure 7 A breast microcyst. The columnar epithelium showing many
apocrine features (basal nuclei, apical snouts) is seen
(H & E x 40)
Figure 8 Microcyst epithelium stained to show the glycolipid
granules present in the epithelium (PAS Diastase x 400)
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Ultrastructural studies confirmed the apocrine nature of the
epithelium of microcysts even when cuboidal (Figure 9). In some
microcysts, part of the epithelium was tall and apical snouts were
present, while in other areas, the cells were more elongated.
However, even in the elongated epithelium, dense granules, numerous
mitochondria and apical microvilli were still present and thus these
cells differ from those lining flattened macrocysts which have none
of these features.
Figure 9 Electron microscopy of microcyst epithelium. The microvilli
the electron dense intracytoplasmic granules and the nucleus
with a prominent nucleolus all features of apocrine
epithelium are present in typical microcyst epithelium
(x 8,000)
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(iii) Peroxidase localisation of DHA sulphate in microcvst
epithelium
Having identified high concentrations of DHA sulphate in the fluid
derived from microcyst epithelium, the aim of the present study was
to determine if high concentrations of DHA sulphate are present
within the cytoplasm of these cells.
Materials and Methods
Frozen sections from six biopsy and two mastectomy specimens
containing 14 microcysts were obtained. DHA sulphate was localised
in these sections by the immunoperoxidase technique previously
described.
All 14 microcysts in the eight specimens contained material in the
cytoplasm of the cells which stained positively with the anti-DHA
sulphate antibody. An example of the deep staining seen in some
microcysts is shown in Figure 10. In these sections the normal
epithelium failed to stain.
Results
.Figure 10 Microcyst epithelium stained for DHA sulphate by the
immunoperoxidase technique. The prominent staining
indicating a high concentration of DHA sulphate is easily
seen (frozen section x 400)
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Discussion
The present study has shown that there exists a single population of
microcysts, lined by epithelium of apocrine type and containing
fluid with a high content of K+ and DHA sulphate. This is in
contrast to the two populations of macrocysts which are lined by
either apocrine or flattened epithelium and differ in electrolyte
and DHA sulphate content. As microcysts are considered to be the
precursors of macrocysts (Wellings 1980, Haagensen et al 1981,
Schwartz 1983), these two populations of macrocysts must arise from
the single population of microcysts. It should be stressed that
microcysts should be clearly distinguished from blunt ducts and they
occur in breasts at a greater frequency than macrocysts (Azzopardi
1979, Haagensen et al 1981, Schwartz 1983). Preliminary studies
suggest that multiple cysts in any one patient are usually all of
the same type, ie all apocrine or all flattened. There may
therefore be factors which determine whether microcysts enlarge and,
if they do so, whether, in any individual, they develop into
apocrine or flattened macrocysts.
The finding of high K+ and DHA sulphate concentrations in microcyst
fluid suggests that these cannot arise by simple lobular dilatation
due to a build up of breast secretions, as the latter contain much
lower levels of K+ and DHA sulphate. This is supported by the
finding of DHA sulphate in the cytoplasm of the epithelium lining
microcysts but not in the cytoplasm of normal lobular epithelium.
It is therefore unlikely that any microcysts arise by simple lobular
dilatation (Wellings 1980). The essential change in the formation
of a microcyst would appear to be the development of apocrine change
within the lobular unit. Other workers have identified
microclusters of apocrine epithelium within lobules in breasts
containing microcysts and have confirmed that microcysts are lined
by uniform apocrine epithelium (Vilanova et al 1983). The active
apocrine epithelium may lead to production of larger amounts of
fluid than normal. The gelatinous nature of microcyst fluid may
account for why it does not drain into the terminal duct. An
alternative reason for the build-up of fluid is that there may be
some obstruction to the outflow, one possible cause being the
hyperplasia that is a frequent accompaniement of microcysts.
However, the inability despite detailed study to find a lesion
causing obstruction in the majority of both micro and macrocysts
suggests that it may not be a necessary or important factor in the
aetiology and development of breast cysts.
This study therefore supports the view that cysts arise in lobules.
It suggests that apocrine secretory activity of the lobule is the
essential feature for cyst development. Only one population of
microcysts has been identified and, as these enlarge, they can
maintain their secretory active apocrine epithelium and to do this
there must be an increase in the number of cells lining the cyst
by hyperplasia or the epithelium may become flattened and attenuated
with little increase in cell numbers. This indicates that all
epithelium lining cysts originates from apocrine epithelium and
would explain why all cyst epithelium stains to some degree with
the apocrine marker, Gross Cystic Disease Fluid Protein 15
(Mazoujian et al 1983). What factors determine whether microcysts
increase in size and whether they retain their active apocrine




Apocrine Differentiation in Human Breast Carcinomas
Introduction
It is of interest in view of the finding that cysts lined by
apocrine epithelium are associated with an increased frequency of
hyperplasia and breast carcinoma, that certain carcinomas show
apocrine differentiation (Azzopardi 1979). It has long been
recognised that malignant change may occur in apocrine epithelium
(Borst 1904, Berka 1911, Krompecher 1913, Cheatle et al 1931, Lee et
al 1933, Ewing 1940, Stewart 1950, Bonser et al 1961). The
epithelium may be lining a breast macrocyst and Bonser et al (1961)
claimed that in 12 of a series of 220 unselected carcinomas arose in
cysts lined by apocrine epithelium. However, origin of a carcinoma
in an apocrine cyst does not automatically mean that the carcinoma
will show apocrine differentiation (Azzopardi 1979). An alternative
theory to explain apocrine differentiation in breast carcinomas is
that apocrine change takes place pari passu with neoplasia
(Azzopardi 1979).
The incidence of apocrine differentiation in reported series varies
according to the definition accepted by the authors. It is
generally accepted that between 2 and 15? of all carcinomas show
marked apocrine differentiation (Geschickter 1943, Bonser et al
1961, Fisher et al 1975, Azzopardi 1979, Dixon et al 1983). These
figures contrast with the 42-68? recorded by Haagensen et al (1981).
A classification of carcinomas into 3 groups based on degree of
apocrine differentiation has been suggested (Dixon et al 1983). The
features shown in Table I, which are accepted as characteristic of
apocrine epithelium, were assessed as present to a marked degree,
present to a moderate degree or absent and Figures 1,2, 3 and 4
show examples of these three groups of tumours. Overall 12$ showed
a marked, 63$ a moderate and 25$ showed no features of apocrine
differentiation. The figure of 12$ with marked apocrine
characteristics is similar to that previously reported and the 75$
showing apocrine differentiation to any degree correlates with the
incidence reported by Haagensen et al (1981).
In this thesis, it has been shown that both apocrine derived
secretion and the cytolasm of apocrine epithelium contain high
concentrations of DHA sulphate. In view of the high concentrations
of androgens associated with apocrine epithelium, it is of interest
that tumours with marked apocrine differentiation have been reported
to metabolise significantly more testosterone in vitro than those
with moderate or absent apocrine features (Dixon et al 1983). This
metabolism was particularly to highly active androgens. It thus
appears that the histological feature of apocrine differentiation
is associated with differences in the handling of androgens and
differences in biological activity.
cytoplasm : copious, acidophilic, granular
glandular
margins: convex, bulbous, apical snouts
nuclei: vesicular with prominent nucleoli
Table I : Features of apocrine epithelium used
to assess degree of apocrine





Breast carcinoma showing a marked degree of apocrine differentiation
(H & E x 100 (Figure 1) and x 400 (Figure 2))
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Figure 3 Breast carcinoma showing a moderate degree of apocrine
differentiation (H & E x 100)
Figure 4 Breast carcinoma having no apocrine features
(H & E x 100)
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Apocrine differentiation In human breast garcj-nQmas
(i) Demonstration of DHA sulphate in human breast carcinomas by
the immunoperoxidase technique
(ii) Correlation of DHA sulphate in human breast carcinomas with
the degree of apocrine differentiation and oestrogen receptor
content
(iii) Electron microscopy of tumours with marked apocrine
differentiation
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Demonstration of DHA sulphate in human breast eareinomas bv the
immnnoneroxidase technique
The aim of the initial study was to determine whether DHA sulphate
could be located in human breast carcinomas.
Materials and Methods
Frozen sections were cut from 20 human breast cancers and DHA
sulphate was localised in the tumours by the immunoperoxidase
technique. The amount of staining within the tumour was scored as
++, + or absent.
Of the 20 carcinomas, 5 showed marked amounts of material (++)
cross-reacting with the antibody, 8 showed minimal staining (+) and
8 showed no staining. Examples of ++, + and absent staining are
shown in Figures 5, 6 and 7. Staining was abolished by pre¬
incubation of the primary antibody with DHA sulphate (Figures 8a and
b). One carcinoma was seen to arise in an apocrine cyst and
staining was present in both benign and malignant areas of the cyst.
Results
Figure 5 Breast carcinoma with a marked apocrine differentiation
stained to demonstrate the presence of DHA sulphate by
the immunoperoxidase technique (frozen section x 200)
Figure 6 Breast carcinoma with a moderate degree of apocrine
















Figure 7 Breast carcinoma with no apocrine features stained for






Figure 8a and b Smear from a breast carcinoma with marked apocrine
differentiation stained to show DHA sulphate (a) and a
negative control (b) whose primary antibody was pre-
incubated with excess DHA sulphate (x 200)
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Correlation of DHA sulphate in human breast carcinomas with degree
of apocrine differentiation and oestrogen receptor concentration
Having identified that material is present in human breast
carcinomas which cross-reacts with the antibody and is therefore
probably DHA sulphate, it was hoped to determine if the amount of
material present correlated with either the degree of apocrine
differentiation within the tumour or the oestrogen receptor
concentration.
Materials and Methods
The degree of apocrine differentiation in a tumour was scored on
haematoxylin and eosin stained sections of the 20 breast carcinomas
in which DHA sulphate had been localised. The tumours were graded
on a 3-point scale as described earlier (marked, moderate or absent
apocrine differentiation).
The oestrogen receptor concentration of each tumour was performed by
Dr R A Hawkins using a saturation method (Hawkins et al 1977). All
procedures were performed in a cold room. The amount of receptor
present was expresed as f mol of receptor / mg tumour cytosol
protein.
Correlation of the amount of DHA sulphate present as assessed by the
immunoperoxidase technique and both apocrine differentiation and
oestrogen receptor concentration was by the Kendall rank correlation
test.
Results
The correlation between apocrine differentiation, oestrogen receptor
and degree of staining by the DHA sulphate antibody peroxidase
technique is shown in Tables I and II. Apocrine differentiation was
significantly correlated with degree of staining, p < 0.01, Kendall-
Rank coefficient = 0.95. Only tumours with low oestrogen receptor
content (<20 fmol/mg cytosol) protein stained to a marked degree
(++) but, overall, the correlation between oestrogen receptor and
degree of staining did not reach statistical significance, p < 0.10
Kendall rank coefficient = 0.35.
Degree of staining with DHA sulphate
antibody-peroxidase technique
Degree of Apocrine Number of




Table I Relationship of degree of apocrine differentiation and
degree of staining with DHA sulphate antibody-peroxidase
technique.
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Degree of staining with DHA sulphate
antibody-peroxidase technique
Oestrogen Receptor Number of








Table III Correlation of oestrogen receptor content and degree of
staining with DHA sulphate antibody - peroxidase
technique.
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Electron microscopy of tumours with marked apocrine differentiation
The aim of this study was to compare and contrast the
ultrastructural appearance of human breast carcinomas showing marked
apocrine differentiation with benign apocrine epithelium within the
breast.
Materials and Methods
Two of the five human breast carcinomas which showed marked apocrine
differentiation were examined by electron microscopy.
In its non-invasive form, the apocrine carcinomas had features
similar to that of benign apocrine epithelium with vesicular nuclei
and prominent nucleoli, cytoplasmic granules and microvilli at the
glandular margins (Figure 9). The cellular contents were, however,
less well organised and the nuclei larger, variable in size and more
irregular. The electron dense intracytoplasmic granules seen in the
subapical position in normal apocrine epithelium were still visible
in the invasive tumour, but were haphazardly distributed within the
cell (Figure 1o), as were the many mitochondria (Figure 11), also a
characteristic feature of apocrine epithelium. Budding of the
apical epithelium was also identified (Figure 12) and this is not a
feature of benign apocrine epithelium.
Results
Figure 9 Electron microscopy of non-invasive 'apocrine' carcinoma.
The nuclei are more irregular than those in normal apocrine
epithelium but still have occasional prominent nucleoli.
Dense intracytoplasmic vacuoles are seen in some cells.
The cells show apical snouts and microvilli (x 6,000)
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•Figure 10 Electron microscopy of an invasive carcinoma with marked
apocrine features. The prominent nucleolus and dense
intracytoplasmic granules characteristic of apocrine
epithelium are easily seen (x 8,400)
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,Figure 11 Further example of an invasive carcinoma with marked
apocrine features (x 10,000)
191
Figure 12 Budding of the cytoplasm in a carcinoma with marked
apocrine features (x 33,400)
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It was also evident that both benign apocrine change and carcinoma
with marked apocrine features were widespread in all sections
examined from each of the two breasts.
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DISCUSSION
This study has shown that carcinomas which show apocrine
differentiation contain high concentrations of DHA sulphate. This
correlates well with the earlier observation that DHA sulphate is
found both in the cytoplasm and fluid derived from benign apocrine
epithelium and confirms the view that DHA sulphate is an apocrine
marker. Tumours with marked apocrine differentiation have been
previously shown to metabolise significantly more testosterone in
vitro than tumours without these features (Dixon et al 1983). As
DHA sulphate can be converted by breast tumours to testosterone
(Miller et al 1976), it seems likely that high concentrations of
active androgens are present within tumours with marked apocrine
differentiation. Apocrine secretion is known to be androgen
dependent (Hurley et al 1960) and it may be that this group of
tumours are dependent o.n androgens. This is in keeping with these
tumours being more commonly oestrogen independent, ie oestrogen
receptor negative. Manipulation of androgens in such patients may
therefore be of some therapeutic benefit.
The ultrastructural studies showed that apocrine carcinomas closely
resemble benign apocrine epithelium in many respects. It was also
evident that in breasts affected by apocrine carcinoma, there was
also benign apocrine change and a range of intermediate stages
of hyperplastic apocrine epithelium with and without atypia. This
raises the question of whether malignancy arises in benign apocrine
epithelium or whether the same factors which institute neoplasia
also cause apocrine change. Whatever the reason, it adds support to






This study has shown that the androgen conjugate DHA sulphate is
present within breast fluids and breast tissues in concentrations
many times greater than those found in plasma. These observations
suggest that the hormonal microenvironment of the breast varies
greatly from that in plasma. Other workers have shown that other
hormones are also present in breast fluids in concentrations greatly
in excess of those in plasma (Raju et al 1977, Wynder et al 1977,
Miller et al 1981, Bradlow et al 1983a). Despite the evidence that
hormones are aetiological in breast cancer, studies of hormones in
plasma and urine have failed to show consistent abnormalities in
those women with breast disease. The finding that the hormonal
milieu of the breast differs greatly from plasma may explain this
and it is possible that the measurement of hormones in breast fluids
may give more accurate information of levels within the breast than
studies on plasma and urine.
The levels of DHA sulphate in breast cyst fluid have been shown to
correlate directly with the K+ content and inversely with the Na+
content of the fluid. On the basis of Na+, K+ and DHA sulphate
levels, two populations of cyst fluids were defined. These two
populations appear to be derived from different types of epithelium,
the fluids with a high DHA sulphate content (low [Na+], high [K+])
being derived from apocrine epithelium and those with a low level of
DHA sulphate (high [Na+], low [K+]) being derived from flattened
epithelium. It is of interest that apocrine secretion from other
sites in the body has been shown to contain a high concentration of
DHA sulphate (Labows et al 1979).
The origin of DHA sulphate in the breast remains uncertain, but the
finding that the concentrations of DHA sulphate in breast secretions
fall after administration of agents which reduce the levels of DHA
sulphate in plasma suggests that it is concentrated from plasma.
This is supported by the work of Bradlow et al (1983a) who showed
that labelled DHA sulphate infused intravenously is found in
breast cyst fluid in levels above that in plasma. The concentration
of DHA sulphate in breast tissues and fluids has been shown in this
thesis to be directly related to the degree of apocrine activity;
epithelium and tumours with marked apocrine differentiation being
associated with the presence of large amounts of this androgen
conjugate. DHA sulphate may therefore be a marker of apocrine
activity and its presence in the breast is in keeping with the view
that the breast is merely a modified apocrine gland (Petrakis
1977a).
Apocrine activity of the breast lobular epithelium may be of
importance in the evolution of breast cysts as the present study has
shown that all breast microcysts are lined by apocrine type
epithelium and contain high concentrations of DHA sulphate. This
activity appears to be a pre-requisite to the development of
microcysts (Vilanova et al 1983). What factors determine the degree
of apocrine activity within the breast remain uncertain, but it is
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known that apocrine glands at other sites of the body are under
partial control by androgens (Hurley et al 1960, Labows et al 1976).
As has previously been noted, the frequency of cysts is reduced by
the oral contraceptive pill (Pastides et al 1983) which reduces
apocrine activity in other apocrine glands (Royal College of General
Practitioners 1974) and also by cyproterone acetate, an
antiandrogenic compound.
DHA sulphate itself has little biological activity. It can,
however, be converted within the breast to a variety of other
steroids including more active androgens and oestrogens (Abul-Hajj
1975, Miller et al 1979, Miller et al 1984). It has been suggested,
for instance, that the other steroid hormones present in cyst fluids
are derived from DHA sulphate (Bradlow et al 1981a, 1983a). An
important finding has been that there are differences in behaviour
in cyst fluids which differ in their concentration of DHA sulphate.
Patients with cysts lined by apocrine epithelium^which contain high
levels of DHA sulphate^are many times more likely to develop further
cysts and may be at a greater risk of breast cancer than those
patients with cysts lined by flattened epithelium. How this
correlates with the finding of Bulbrook et al (1976) that it is
women with reduced urinary excretion of androgen metabolites who are
at increased risk of breast cancer is uncertain, although this study
has clearly shown that there is little direct relationship between
plasma, urine and breast levels of steroids and has therefore
questioned the relevance of measurements of steroids in urine or
plasma. The measurement of DHA sulphate in breast fluids appears to
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provide a method of assessing the degree of apocrine activity within
the breast. As apocrine activity appears related to the
et al
development of both benign (Azzopardi 1979, Schuerchj1982, Vilanovaetal
1983) and malignant breast disease (Azzopardi 1979, Haagensen et al
et al
1981, Schuerchyh982), further studies of this androgen conjugate in
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Classification of human breast cysts according
to electrolyte and androgen conjugate
composition
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One hundred human breast cyst fluids have been analysed for sodium (Na+),
potassium (K+) and dehydroepiandrosterone (DHA) sulphate. Concen¬
trations varied greatly between individual cyst fluids, Na+ from 20 to
185 mmol/1, K+ from 5 to 160mmol/l and DHA-sulphate from 1*5 to
87 jlmol/1. Analysis of the inter-relationships between Na+, K+ and DHA
sulphate revealed two major sub-populations of cyst fluids—one group in
which Na+ levels were markedly in excess of K+ and DHA sulphate concen¬
trations were low and the other in which K+ was the predominant cation and
DHA sulphate concentrations were high.
Introduction
In Western countries, 7% of women present with a palpable cyst in the breast
(Haagensen et al.y 1981). Women with cystic disease are believed to have an increased
risk of developing breast cancer (for reviews see Azzopardi, 1979; Haagensen et al.,
1981), yet comparatively little is known about the aetiology of cysts or the composition
and derivation of cyst fluid.
Recent work on the composition of cyst fluid has shown that concentrations of elec¬
trolytes (Gatzy et al.y 1979; Bradlow et al., 1981 b) and conjugates of androgens (Bradlow
et al., 1981#; Miller et al., 1982) and oestrogens (Raju et al, 1977) vary widely between
individual cyst fluids.
The present study describes the interrelationships between concentrations of electro¬
lytes and androgen conjugates and suggests a classification of cyst fluids on the basis
of these constituents.
Materials and methods
One hundred breast cyst fluids were obtained by needle aspiration from 85 patients.
In 75 subjects a single cyst was aspirated but, in 10, multiple cysts were drained (Table
1). Volumes varied from 0*7 to 50 ml.
*J. M. Dixon is a Wellcome Surgical Research Fellow.
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Table 1. Electrolyte classification of multiple cysts
Breast 1 Breast 2
Patient Cyst 1 Cyst 2 Cyst 3 Cyst 1
1 Na+ Na+




6 K+ K+ K+ K+
7 K+ K+
8 K+ K+
9 K+ K+ Mix





















Figure 1. Concentrations of sodium and potassium in human breast cyst fluids. Horizontal lines
represent mean level. Vertical lines represents reference range for human plasma.
Estimates of concentrations of Na+ and K+ were performed by flame photometry
(EEL model 150 flame photometer) on cyst fluids diluted 1:200 in distilled water.
Androgen conjugates were measured by radioimmunoassay using an antibody
described previously (Miller et al., 1980). While this antibody is largely specific for
dehydroepiandrosterone and its sulphate, it does cross-react with epiandrosterone con¬
jugates. The results from the radioimmunoassay therefore reflect levels of both DHA
sulphate and closely related androgen conjugates (levels of free DHA are very low in
comparison with conjugated steroid). For simplicity, however, values from the radio¬
immunoassay have been expressed as units of 'DHA sulphate'. All statistical analyses
were performed using non-parametric tests (Kendall Rank and Wilcoxon Rank tests
as indicated).
Results
The levels of Na+ and K+ in the cyst fluids are shown in Figure 1. Values for both
ions varied enormously and, in the case of potassium, were usually greatly in excess




Figure 2. DHA-sulphate levels in human breast cyst fluids. Dotted vertical lines represent range
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Figure 3. Relationships in human breast cyst fluid between (a) Na+ and K+; (b) DHA sulphate
and Na+; (c) DHA sulphate and K+. Significance values from Kendall rank test.
of the reference range in plasma. Distribution about the mean of values for both ions
was suggestive of there being more than one population of cyst fluids.
The concentrations of DHA-sulphate in each of the 100 human breast cyst fluids
is shown in Figure 2. Levels varied from 1 - 5 to 870 Jimol/l with a median value of
80 |imol/l.
Interrelationships between K+, Na+ and DHA-sulphate are shown in Figures 3(a),
(b) and (c). These were all statistically significant by the Kendall Rank test (/> < 0 • 001
in each case). The correlations between Na+ and both K+ and DHA sulphate were








Figure 4. Ratio of Na+/K+ in human breast cyst fluids. Lines represent arbitrary divisions to

















Figure 5. DHA sulphate levels in human breast cyst fluids subdivided according to electrolyte
classification Na+ represents fluids with Na+: K+>4, mix fluids with Na+: K+ 1—4 and K+
fluids with Na+: K+ <1-0.
inverse relationships whereas that between K+ and DHA sulphate was in a positive
direction.
As the distribution of values for both Na+ and K+ suggested that there was more
than one population of cyst fluids, the 100 samples examined were arbitrarily subdivided
into three groups according to Na+ and K+ by means of their concentration ratio
(Figure 4). One group was of 47 fluids in which the K+ concentration exceeded that
of Na+ (K+ fluids), another of 43 fluids in which the Na+ concentration was above
four-fold higher than that of K+ (Na+ cyst fluids), and a further group of 10 fluids
with intermediate electrolyte values (mix cyst fluids). Values for DHA-sulphate in these
subgroups of fluids are shown in Figure 5. Concentrations of DHA-sulphate in K+ cyst
fluids were significantly higher than the Na+ group (/> < 0 • 0005). Levels in the mix
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category were similar to the K+ group but significantly higher than the Na+ group
(/>< 0-001).
Ten patients had multiple cysts aspirated on the same day. The electrolyte classifica¬
tion is shown on Table 1. In eight women, multiple cysts were of the same electrolyte
group; two patients had cysts of different grouping although in one case the cysts
co-existed within the same breast.
Discussion
Although the present study confirms that levels of Na+, K+ and DHA-sulphate vary
widely between different cyst fluids (Bradlow et al., 1981#, b\ Miller et al., 1982), it
has shown that there are significant associations between the concentration of these
constituents. Thus, levels of Na+ are inversely correlated with concentrations of both
K+ and DHA-sulphate. The values for Na+ and K+ are also not distributed symmetri¬
cally about their mean values and distribution is suggestive of more than one population
of cyst fluids. It is possible to use the relative concentrations of Na+ and K+ to identify
presumptive sub-groups of cyst fluids. This arbitrary classification based on electrolyte
composition also subdivides the cyst fluids into those with high or low levels of DHA
sulphate.
It therefore can be shown that 90% of cyst fluids fall into one of two major sub¬
groups—one type (K+ fluids) contains high concentrations of K+ and DHA-sulphate
and low concentrations of Na+ whereas the other type (Na+ fluids) has the reverse
composition. Bradlow and his colleagues (198H) have independently classified cysts
on electrolyte composition but found a higher proportion of K+ cysts as compared with
the present study.
The derivation of Na+ and K+ subgroups of cyst fluids still remains to be defined.
They may reflect different sources of constituents or differences in secretory activity
of the epithelium lining the cysts. The composition ofNa+ cysts is akin to that of plasma
in respect of Na+, K+ and DHA-sulphate. However, although DHA-sulphate levels
in K+ cyst fluids are similar to those in breast secretions obtained by nipple aspiration
(Miller et al., 1981), Na+ is the predominant ion in such breast secretions. Simple
accumulation of these breast secretions is therefore unlikely to account for the formation
of K+ cyst fluids.
It seems more likely that the constituents of K+ cyst fluids result from apocrine
activity by the epithelium lining the cyst. Apocrine secretions characteristically contain
high concentrations of K+ and DHA-sulphate (Labows et al., 1979). Our preliminary
results examining cells lining the walls of excised cysts would support this concept.
The relevance of this classification of breast cyst fluids still remains to be elucidated
and it should be noted that different types of cyst fluids may co-exist within the same
breast although it is more usual for multiple cysts to be of the same type. It may be,
however, that a sub-population of cysts occurs in women at high risk of epithelial
proliferative changes including cancer.
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The morphological basis of human
breast cyst populations
J. M. DIXON, W. R. MILLER,
W. N. SCOTT AND
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University Department of Clinical Surgery,
Royal Infirmary, Edinburgh EH3 9YW.
Forty human cysts have been examined to determine the relationship
between the epithelial lining and the content of sodium (Na +) and
potassium (K+) in the cyst fluid. The ratios of Na+ to K+ for cysts
lined by flattened epithelium were higher in all cases than the values
obtained for cysts lined by apocrine epithelium. These findings
suggest a morphological basis for the two populations of human
breast cyst fluids which can be defined on cationic content.
Human breast cyst fluids can be separated into two major
populations on the basis of the relative concentrations of
sodium (Na + ) and potassium (K + ) (1, 2). The two major
groups are: (i) fluids in which concentrations of K + exceed
those of Na + ; and (ii) fluids in which levels of Na+ greatly
exceed those of K + . Cyst fluids in which K + is the predominant
cation contain high concentrations of the androgen conjugate
dehydroepiandrosterone sulphate (DHA sulphate) (2) and
contain the secretory (lis) form of immunoglobulin A (IgA)
(3. 4), indicating that the epithelium lining such cysts is active
and secretory. In contrast cyst fluids in which Na+ greatly
predominates, contain low levels of DHA sulphate (2) and the
non secretory (7s) form of IgA and would be indicative of a less
active epithelium. To date, however, no evidence has been
reported to show that differences in breast cyst composition are
associated with the nature of the lining epithelium. The aim of
the present study was to investigate the relationship between
the morphology of epithelium of human breast cysts and the
cationic content of cyst fluid.
Materials and methods
Morphological assessment of the epithelium lining 40 human breast
cysts was performed either by: (i) centrifuging an aliquot of cyst fluid
and examining the stained deposit cytologically (26 cysts from 22
patients); or (ii) dissecting cysts from tissue obtained at mastectomy or
biopsy and submitting the cyst wall for histological processing and
serial sectioning (7 cysts from 6 mastectomy specimens and 7 cysts from
6 biopsy specimens).
The aspirates of cyst fluid were stained by Papanicolaou's technique
(Pap) and by periodic acid Schitf after diastase digestion (PAS diastase).
Dissected cyst specimens were stained by haematoxylin and eosin
(H & E) and PAS diastase. PAS diastase positive granules in the
cytoplasm of cells were used as a positive method of identification of
apocrine epithelium (5). All cyst fluid aspirates and dissection speci¬
mens were assessed by a consultant pathologist with a specific training
in breast histology and cytology.
The concentration of Na + and K + in the 40 cyst fluids was measured
by flame photometry (EEL model 150 flame photometer) on a 1 in 200
and a 1 in 400 dilution of cysts fluid in distilled water.
Results
It was possible to identify two major types of epithelial cells in
both cytological and dissection preparations: (i) acidophilic
cells (on H & E) with copious granular cytoplasm containing
PAS diastase positive granules, luminal apical snouts and
nuclei showing prominent nucleoli—apocrine epithelium; (ii)
basophilic cells (on H & E) having less cytoplasm and contain¬
ing no PAS diatase positive granules^)7a//e«<?t/ epithelium.
Figs. 1 and 2 show examples of apocrine and flattened
epithelial cells in breast cyst aspirates. Fig. 3 shows the specific
glycolipid granules in the cytoplasm of apocrine cells. Figs. 4
and 5 demonstrate apocrine and flattened epithelium in dis¬
section specimens with Fig. 6 showing the apical position of the
glycolipid granules in apocrine epithelium.
In this series no cyst showed a mixture of apocrine and
flattened epithelium in either aspiration or dissection speci¬
mens. In 22 cysts the lining was assessed as apocrine (14
aspiration and 8 by dissection) and in 18 the lining was
Fig. 1. Cytological preparation of a cyst aspirate showing apocrine
cells. The cells have copious pale granular cytoplasm with vesicular
nuclei showing prominent nucleoli (Pap x 480).
Fig. 2. Cytological preparation of a cyst aspirate showing simple
flattened epithelium. The cells have small amounts of cytoplasm,
deeply staining nuclei and no special features (Pap x 480).
flattened simple epithelium (12 by aspiration and 6 by dis¬
section).
The correlation between the morphology of the lining epi¬
thelium as assessed in cytological preparations and dissection
specimens and the Na + /K+ ratio is shown in Fig. 7. Cysts with
flattened epithelium had significantly higher Na + /K+ ratios
than cysts lined by apocrine epithelium (P<0001 Wilcoxon's
Rank Sum test). On the basis of Na + /K+ ratios it was possible










Fig. 3. Cylological preparation of a cyst aspirate stained to show the
specific glycolipid granules found in apocrine cells. The vesicular nuclei
with prominent nucleoli, also a feature ofapocrine epithelium, are easily









Fig. 7. The ratios of sodium (Na + ) and potassium (K+ ) in the
cysts where the epithelium was assessed as apocrine or flattened by
examination of aspiration and dissection preparations.
Fig. 4. Dissection specimen of an apocrine cyst. The cells are
columnar and have basally situated nuclei, abundant cytoplasm and
apical snouts containing deeply staining intracytoplasmic glycolipid
granules (H & Ex 128).
to distinguish completely between apocrine and flattened epith¬
elial cysts, those cysts lined by apocrine epithelium having a
ratio of 2 or less and those lined by simple flattened epithelium
a ratio of greater than 3.
I
Fig. 5. Dissection specimen of a flattened epithelial cyst. The
epithelium is attenuated and flattened and few cells are visible in any
one section (H & Ex 256).
4
Fig. 6. Dissection specimen showing the apical position of the
glycolipid granules in apocrine epithelium (PAS diastase x 256).
Discussion
Approximately 7 per cent of all women in the Western world
develop a breast cyst (6). Certain studies have shown that these
women are at increased risk of developing breast cancer (5, 6)
although others have been unable to confirm this finding (7). In
view of their frequency and their possible relationship to breast
cancer, it is surprising that little is known of the composition or
derivation of human breast cysts. Recently breast cyst fluids
have been divided into two major groups on the basis of the
relative concentrations of Na+ and K+ (1, 2, 8). These two
groups of fluids have also been shown to contain significantly
different levels of the androgen conjugate DHA sulphate and
to contain different molecular forms of IgA (2-4). The present
study has demonstrated that the epithelia lining these two
groups of cysts are morphologically different. All cysts where
the Na+/K+ ratio was 2 or less were lined by apocrine
epithelium and those with a ratio of greater than 3 were lined
by flattened epithelium.
This subdivision on the basis of the Na+ /K+ ratio is similar
to that used by us to discriminate between cysts with high and
low DHA sulphate (1,2). Cysts with a low Na+ /K.+ ratio had
high levels ofDHA sulphate. Such cysts have been shown in the
present study to be lined by apocrine epithelium. It is of note
that apocrine secretion from axillary skin has also been shown
to contain high concentrations of DHA sulphate (9).
Electron microscopic studies of breast cyst epithelium have
shown that apocrine cells contain many mitochrondria and
apical secretory granules, in contrast to flattened epithelial cells
which contain few organelles (10). Apocrine secretion is per¬
formed by expelling the contents of the intracellular secretory
granules and is more accurately termed merocrine (5). The
k
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finding of high potassium, the major intracellular cation, in
cysts lined by apocrine epithelium, correlates well with what is
known of the ultrastructure and method of secretion of
epithelium of apocrine type.
Studies of patients with multiple cysts in one or both breasts
have shown that, in the majority, the cysts had a similar
electrolyte composition (2) and were therefore likely to be lined
by the same type of epithelium. This observation suggests there
may be a factor which determines whether patients develop
cysts lined by apocrine or flattened epithelium. Apocrine
change has been reported to occur more frequently in popula¬
tions at high risk of breast cancer (11-13) and the results from
this study show that the presence of apocrine epithelium in
cystic disease may be detected by electrolyte analysis of breast
cyst fluid. It is therefore possible that such analysis will be
helpful in identifying patients at increased risk of breast cancer.
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INTRODUCTION
> reast cysts were first distinguished
^from carcinomas in 1829 by Astley
Cooper1. They are the commonest
cause of a benign breast mass affecting
approximately 7 per cent of all women
in the Western World2. It has been
reported that these women may be at
increased risk of subsequent breast
cancer2,3. In view of the length of time
which has passed since their identifica¬
tion, their frequency and association
with hyperplasia and breast cancer, it is
surprising that comparatively little is
known of the content and derivation of
human breast cysts. »
Composition
Recentlv electrolytes4,5 and
hormones6, in cyst fluids have been
measured and shown to vary widely
between individual cysts. We have
measured sodium (Na+), potassium
(K+) and the androgen conjugate
dehydroepiandrosterone sulphate
(DHA sulphate) in 100 cyst fluids and
confirmed this wide variation. (Figures
1 and 2). However, we found signifi¬
cant interrelationships between these
three substances, with inverse correla¬
tions between Na+ and both K+ and
DHA sulphate and a direct correlation
between and DHA sulphate (Fi¬
gures 3a, b and c). It was also evident
















plasma cyst breastfluids secretions
Figure 1. Concentrations of sodium and
potassium in human breast cyst fluids.
Horizontal lines represent mean values.
Vertical lines represent reference range
for plasma.
6
Figure 2. DHA sulphate levels in human
breast cyst fluids. Dotted vertical lines
represent range in human plasma and
breast secretions obtained by nipple
aspiration. Horizontal lines represent
median values.
normally distributed around the mean,
indicating that there may be more than
one population of cyst fluids. This was
particularly evident in a plot of the
ratio of Na"1" to K+ (Figure 4). Cyst
fluids could be divided into two groups,
one having a high and the other a low
Na+/K+ ratio. DHA sulphate concen¬
trations in these two populations were
significantly different, levels being
higher in fluids with low Na"7K+ ratios
(Figure 5).
Further studies have shown that pH,
concentration of albumin and IgG and
type of IgA also vary in the two
populations of cyst fluids as defined by
electrolyte content.
Relationship of epithelial lining of
cysts and cyst fluid composition
Morphological studies of the epithe¬
lium lining breast cysts have been
undertaken to determine w hether dif¬
ferences in the composition of the two
populations of breast cysts are related
to the nature of the lining epithelium.
The epithelium lining 40 breast cysts
was characterised by either histology
or cytology. This was then compared
with the composition of the cyst fluid.
Two types of epithelium were identi¬
fied in both histological and cytological
preparations:-
(1) acidophilic cells on haematoxylin
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Figure 3. Relationships in human breast
cyst fluid between (a) Na+ and (b)
DHA sulphate and Na+ (c) DHA sul¬
phate and K+. Significance values from
Kendal rank test.
E), with copious cytoplasm con¬
taining granules which stain by the
periodic acid Schiff (PAS) techni¬
que after diastase digestion, have
luminal snouts and nuclei with
prominent nucleoli — apocrine
epithelium.
(2) basophilic cells (on H and E)
having less cytoplasm with no
specific features — flattened
epithelium.
Figures 6, 7, 9 and 10 show examples of
apocrine and flattened cells in histolo¬
gical and cytological preparations with
the PAS positive glycolipid granules
characteristic of apocrine epithelium
being demonstrated in Figures 8 and
11.
Comparison of the epithelial lining
































Figure5. DHA sulphate in human breast
cyst fluids subdivided according to elec¬
trolyte classification into fluids with high
Na IK+ and low Na+/K ratio.
and aspiration specimens and the Na+/
K+ ratio in cyst fluid (Figure 6) showed
all cysts lined by apocrine epithelium
had a lower Na+/K"^ ratio than those
lined by flattened epithelium. Similarly
subdivision of cysts according to histol¬
ogy of the epithelial lining split DHA-
sulphate values into two separate
groups, those with apocrine epithelium
having high concentrations and those
with flattened epithelium having low
concentrations of DHA sulphate (Fi¬
gure 13).
Apocrine cyst fluids thus have a low
Na+/K+ ratio and high concentrations
of DHA sulphate. Apocrine secretion
occurs by expulsion of cellular contents
via intracvtoplasmic vacuoles2 and the
finding of high potassium concentra¬
tions in fluids derived from apocrine
"«• - *- -aS - »
, -l ■>— —-A. -;
Figure 6. Histological specimen of an
apocrine cyst. The cells are columnar,
have basally situated nuclei, apical
snouts and abundant cytoplasm contain¬
ing intracytoplasmic glycolipid granules
(H & E X 240).
breast cyst fuids. Two populations are
evident, one with a high and the other
with a low A'a+/A'+ ratio.
Figure 8. Histological specimen showing
the apical position of the PAS positive
glycolipid granules in apocrine epithe¬
lium. (PAS Diastase X 320).
cells is consistent with this activity. It is
of interest that apocrine secretion from
axillary skin has been shown to contain
high concentrations of DHA
sulphate8. It is also of note that the
colour range of apocrine axillary sweat
(yellow to green to .bluish black) is
identical to that seen in breast cysts9.
Relationship of cyst fluid
populations to natural history and
breast cancer risk
Whilst two populations of breast
cysts may be defined on the basis of
composition and the nature of epithe¬
lial lining, it remains to determine
whether these two subgroups have any
clinical relevance. Preliminary studies
suggest that these two groups differ in
terms of their natural history and their
association with the subsequent de¬
velopment of breast cancer.
We know that about half of all
women, who present with cystic dis¬
ease will have a single cyst, a third of
patients will develop between 2 and 5
cysts and the remainder have in excess
of 52. Our own data from a prospective
analysis of 100 consecutive patients
followed over 2 years show 45 per cent
of patients had 1 cyst, 46 per cent had
2-5 cysts and 9 per cent had in excess of
5. All cysts aspirated from these 100
patients were classified on the basis of
electrolyte composition as apocrine
(Na + /K"f<3) or flattened (Na + /
'A'
ti *^5 -s.-L ■-*
•vc /
Figure 9. Cytological preparation of a
cyst aspirate showing apocrine cells. The
cells have copious pale granular cyto¬
plasm with vesicular nuclei showing
prominent nucleoli (Papanicolaou X
480).
Figure 7. Histological specimen of a
fattened epithelial cyst. The epithelium
is flat and attenuated and has no specific
features (H &. E X 480).
Figure 10. Cytological preparation of a
cyst aspirate showing simple flattened
epithelium. The cells have a small
amount of cytoplasm, deeply staining
nuclei and no special features. (Papani¬
colaou X 480).
Figure 11. Cytological preparation of a
cyst aspirate stained to show the specific
glycolipid granules found in apocrine
cells. The vesicular nuclei with promin¬
ent nucleoli, also a feature of apocrine
epithelium are easily seen. (PAS diastase
X 480).
K+^3). The relationship of cyst type to
the natural history of cystic disease was
then examined.
Of the 100 patients, 43 developed
single or multiple cysts of flattened
type, 44 patients developed single or
multiple cysts of apocrine type and 13
patients had mixtures of the two types
of cysts. Patients with a single cyst were
more likely to have a flattened cyst and
as the number of cysts aspirated in each
patient increased, so the proportion of
apocrine cysts also increased. (Table
])-
There were 56 episodes where pa¬
tients had multiple simultaneous cysts
and in 48 (88 per cent) all cysts were of
the same type, ie all apocrine or all
flattened. A total of 43 patients de¬
veloped sequential cysts and in 32 (74
7
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apocrine flattenedFigure 12. Ratio ofSa+/K+ in cystfluids
where the lining epithelium of thi cyst
was assessed as apocrine or flattened by
examination ofhistological or aspiration
specimens.
per cent) of these, all cysts aspirated
over the two year period were of the
same type. Thus, patients who have
multiple cysts, whether they are simul¬
taneous or sequential usually develop
cysts of one or other type.
A comparison of. the frequency of
further cysts in the groups of patients
who presented with either apocrine or
flattened cysts showed that patients
who had single or multiple apocrine
cysts were more than 5 times more
likely to develop further cysts.
A review of 400 patients with breast
cancer identified 10 patients who had a
previous history of cyst aspiration
where toe aspirated cysts could be
classified on the basis of cytology or
electrolyte composition. Nine of these
patients had single or multiple apoc¬
rine cysts and one had a single flattened
Table ItComg 'rison ofthe % ofcysts which were classified as fattened or apocrine by
electrolyte comj osition in group ofpatients who had totals of1,2-5 or >5 cysts
aspirated over a.^ yearperiod.
Figure 13. DHA sulphate levels in cyst
fuids where the lining epithelium of the
cyst was apocrine or flattened.
cyst. This ratio is markedly different to
that in the general population with
cystic disease (see above) and is in
keeping with other observations that
apocrine change occurs more frequent¬
ly in populations at risk of breast
Conclusion
Two populations of human breast cysts
can be identified. They differ in the
nature of the lining epithelium and the
composition of cyst fluid. Preliminary
studies show that the groups are associ¬
ated with clinical differences in natural
history. It is also possible that these
two groups also differ in their associa¬
tion with subsequent breast cancer.
Larger numbers of patients and further
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pH ofhuman breast cyst fluids
J. M. Dixon, W. R.Miller andW. N. Scott
University Department ofClinical Surgery, Royal Infirmary, Edinburgh
EM3 9YW
(Accepted for publication 4 June 1984)
The pH of 106 human breast cyst fluids has been measured immediately
following aspiration. Values ranged from pH 6 ■ 3 to 7 • 8. They correlated with
the ratio of Na+ to K+ in cyst fluid and differed significantly in the two popu¬
lations of fluids which can be defined on electrolyte composition. Storage of
cyst fluid for one month at — 20°C resulted in an increase in pH by a mean
of 0-9 of a unit. pH provides a simple method for typing cyst fluids and
this may be of clinical importance as there is evidence that there are differ¬
ences in the natural history and association with breast cancer in the two
populations of breast cysts.
Introduction
Two separate populations of human breast cysts can be defined on the basis of the
ratios of sodium (Na+) to potassium (K+) in cyst fluid (Bradlow et al., 1981; Dixon
et al., 1982; Miller et al., 1983). It has been shown that this variation in fluid com¬
position reflects different types of epithelium lining the two groups of cysts (Dixon
et al., 1983a).
The aims of the present study were to measure the pH of fresh cyst fluid and to
determine if differences in pH exist between the two populations of cyst fluids defined
on electrolyte composition and to investigate the effect of storage on pH.
Patients, materials and methods
One hundred and six breast cyst fluids were aspirated from 74 patients into air tight
syringes, placed on ice and pH measured within one hour, using a Corning 178
pH/blood gas analyser. Na+ and K+ concentrations were measured in the same fluids
by flame photometry (EEL model 150 flame photometer) after dilution 1 in 200 and
1 in 400 with distilled water. Fluids were then stored at — 20°C and pH was remeasured
in 10 samples after 1 week and 1 month of storage.
Statistical correlation of pH and Na+/K+ ratio was by the Kendall rank test. Com¬
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Figure 2. Correlation of pH and the Na+/K+ ratio of 106 breast cyst fluid.
Results
The pH values of the 106 cyst fluids ranged from 6-3 to 7-8 (Figure 1). There was
significant positive correlation between pH and Na+/K+ ratio, p < 0 • 001 by the Kendal
rank test (Figure 2). Composition of pH in fluids subdivided into different types accord¬
ing to Na+/K+ ratio showed no overlap in values between the two populations (Figure
3), the difference between the groups being significant by the Wilcoxon rank sum test
(/><0 001).
The effect of storage on pH in 10 cyst fluids is shown in Figure 4. After 1 week
pH had increased in all fluids by a mean of 0 ■ 4 and by 1 month it had increased further
by a mean of 0 ■ 9 of a pFl unit over initial values.
Cyst fluids











Figure 3. pH of cyst fluids separated into two populations on the basis of Na+/K+ ratio. The
















Figure 4. Effect of storage on pH in 10 cyst fluids.
Discussion
Human breast cyst fluids have been previously reported to be alkaline, with a pH range
of 7-6—9 0 (Gatsy et al., 1979). These measurements were however performed on
stored samples and this study has shown that fresh cyst fluids are acidic or neutral
and only become alkaline on storage. pH has been shown to correlate with the ratio
of Na+ to K+ in cyst fluid and to differ in the two populations of cyst fluids defined
on the basis of Na+/K+ ratio. Cysts with a low Na+/K+ ratio are thought to be lined
by apocrine epithelium and cysts with a high ratio to be lined by flattened epithelium
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pH than flattened cysts. This is of interest as apocrine secretion occurs by expelling
the contents of intracellular secretory granules (Azzopardi, 1979) and intracellular fluid
has a lower pH than extracellular fluid (Waddell & Bates, 1969). Apocrine secretion
from the axilla has also been noted to be acidic (Hurley & Shelley, 1960). In contrast
the fluid in flattened cysts is considered to arise by transudation (Dixon et al., 1983^).
The findings of different pH values in the two groups of cysts thus correlate well with
the different modes of formation which have been proposed.
It appears that patients with apocrine cysts are more likely to develop further cysts
and may be at a greater risk of breast cancer (Haagensen et al., 1981; Dixon & Miller
unpublished). As apocrine cyst fluids are acidic, measurement of pH may be useful
in the determination of cyst fluid type. Recently we have used Multistix (Ames Division
Miles Laboratories Limited, England) to assess pH immediately after aspiration. This
has proved a useful, simple method of identifying cyst fluid type and studies on its
value are continuing.
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